WO2005111102A1 - Polymer for preventing protein adhesion and composition containing the same - Google Patents

Polymer for preventing protein adhesion and composition containing the same Download PDF

Info

Publication number
WO2005111102A1
WO2005111102A1 PCT/JP2004/016652 JP2004016652W WO2005111102A1 WO 2005111102 A1 WO2005111102 A1 WO 2005111102A1 JP 2004016652 W JP2004016652 W JP 2004016652W WO 2005111102 A1 WO2005111102 A1 WO 2005111102A1
Authority
WO
WIPO (PCT)
Prior art keywords
meth
polymer compound
monomer
mass
polymer
Prior art date
Application number
PCT/JP2004/016652
Other languages
French (fr)
Japanese (ja)
Other versions
WO2005111102A9 (en
Inventor
Yusuke Hara
Yoshio Shimizu
Masanori Komatsu
Kiyoharu Itoh
Manabu Hattori
Original Assignee
Lion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2004143177A external-priority patent/JP4730506B2/en
Application filed by Lion Corporation filed Critical Lion Corporation
Publication of WO2005111102A1 publication Critical patent/WO2005111102A1/en
Publication of WO2005111102A9 publication Critical patent/WO2005111102A9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/42Nitriles
    • C08F220/44Acrylonitrile
    • C08F220/48Acrylonitrile with nitrogen-containing monomers

Definitions

  • the present invention relates to a polymer compound for preventing protein adhesion and a composition containing the same.
  • the present invention relates to a polymer compound for preventing protein adhesion having an excellent ability to prevent protein adhesion, and a composition containing the same. More specifically, glass, ceramic, stainless steel, plastic, and the like, which are used as materials for medical devices and the like, and there is a concern that the biocompatibility of the material may be impaired by the attachment of biological substances such as proteins. Adhesion to hard surfaces such as skin, soft surfaces such as hair and fibers, and gel surfaces, especially contact lens surfaces, even when treated at low concentration and for a short time, and durable and excellent protein adhesion The present invention relates to a polymer compound for preventing protein adhesion imparting a protective ability and a composition containing the polymer compound.
  • Patent Document 1 As a surface treatment agent, a polymer compound containing a tertiary amino group, a detergent composition, an antifouling agent composition, and a cleaning antifouling agent composition have been proposed (for example, Patent Document 1). : See JP-A-2002-256030). Specifically, it is a polymer compound containing a polyoxyalkylene oxide-containing monomer as an essential component, and contains a detergent for contact lenses to prevent contamination of tear-derived proteins. Excellent effect It is what is done. However, in the case of protein stains only, a further effect has been desired with respect to durability such that it remains without being washed off from the coated surface during long-term use. In addition, although it has excellent anti-adhesion properties against various contaminants, it is desired to further prevent protein adhesion by short-time treatment or low-concentration polymer compound solution treatment!
  • Patent Document 2 JP-T-2000-510186. Gazette.
  • compositions and methods for inhibiting the accumulation of proteins in contact lenses have been proposed.
  • the content of the quaternary amine functional group is too high, in order to prevent protein adhesion, which is the object of the present invention, it may be adsorbed on the surface by short-time treatment or treatment with a low-concentration polymer solution. And a function of imparting an excellent protein adhesion prevention ability cannot be obtained.
  • ionic polymer compounds for use in contact lenses have been proposed (see, for example, Patent Document 3: JP-A-54-116947). Specifically, a composition and a method have been proposed which increase the surface moisture by coating the surface of the ionic contour lens with a polymer compound having a charge opposite to that of the surface and having a high water retention ability. ing.
  • a composition and a method have been proposed which increase the surface moisture by coating the surface of the ionic contour lens with a polymer compound having a charge opposite to that of the surface and having a high water retention ability. ing.
  • the function of adsorbing to the surface even by short-time treatment or treatment with a low-concentration polymer compound solution to impart excellent protein adhesion prevention ability Cannot be obtained.
  • Patent Document 4 Japanese Patent Application Laid-Open No. 150014/1993
  • lipid dirt adheres by making the lens hydrophilic with the polymer compound.
  • Patent Document 4 Japanese Patent Application Laid-Open No. 150014/1993
  • the present invention aims to prevent protein adhesion by adsorbing to the surface even by short-time treatment or treatment with a low-concentration polymer compound solution. The function to be given cannot be obtained.
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2002-256030
  • Patent Document 2 JP-T-2000-510186
  • Patent Document 3 JP-A-54-116947
  • Patent Document 4 JP-A-1-50014 Disclosure of the invention
  • the present invention has been made in view of the above circumstances, and is used as a material for medical devices and the like, and the biocompatibility of the material is poor due to the attachment of a biological substance such as a protein.
  • Excellent protein adherence to hard surfaces such as glass, ceramics, stainless steel, and plastics, soft surfaces such as hair and fibers, gel surfaces, and contact lens surfaces, etc., which may cause danger, even when treated at low concentration and for a short time.
  • An object of the present invention is to provide a polymer compound for preventing protein adhesion, which has an inhibitory ability and has an excellent durability.
  • an antifouling agent composition that is not easily washed away even by rinsing with water and is adsorbed on the target surface and exhibits antifouling properties
  • a cleaning antifouling composition that has antifouling properties simultaneously with cleaning, and ophthalmic use It is intended to provide compositions and compositions for contact lenses.
  • the present inventors have found that a monomer having a specific tertiary amino group and a monomer having Z or a specific quaternary ammonium group, A polymer compound obtained by copolymerizing an acrylic acid ester monomer and a nonionic water-soluble monomer in a specific amount and having a weight average molecular weight of 5,000 to 1,000,000. It has been found that even when the surface and the gel surface are treated at a low concentration for a short time, the gel has a durable protein adhesion preventing ability.
  • the inclusion of the above-mentioned polymer compound in the water-soluble composition allows it to be adsorbed on the target surface even at low concentration and for a short period of time, and has an excellent ability to prevent protein adhesion.
  • the present inventors have found that the copolymer is not washed out in a washing step involving rinsing, and is adsorbed on an object surface as an active ingredient to exhibit antifouling properties, and the present invention has been accomplished.
  • the present invention is obtained by copolymerizing the following (A), (B) and (C), and has a weight average molecular weight
  • a polymer compound for preventing protein adhesion of 5,000 to 1,000,000, and an antifouling agent composition, a cleaning antifouling agent composition, an ophthalmic composition, and a contact containing the high molecular compound A composition for a lens is provided.
  • R 1 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • RR 3 is independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms
  • R 4 and R 5 are Independently, it represents a linear or branched alkyl group having 1 to 4 carbon atoms
  • m is 0, 1 or 2.
  • R 6 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • R 7 and R 8 are each independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms
  • R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms
  • n is 0, 1 or 2
  • X is halogen, OH, 1 / 2SO, HSO, 1 / 3 Indicates PO, HCO or CH CO.
  • R 12 is a hydrogen atom or a methyl group
  • R 13 is a linear or branched alkyl group having 16 carbon atoms.
  • the biocompatibility of a material may be deteriorated due to the attachment of a biological substance such as a protein when used as a material for a medical device or the like.
  • a polymer compound for preventing protein adhesion which is durable and has an excellent protein adhesion preventing ability even when treated at a low concentration and for a short time on a gel surface and a contact lens surface, and is useful as an antifouling agent.
  • An antifouling agent composition, a cleaning antifouling agent composition, an ophthalmic composition and a contact lens composition containing the same can be provided.
  • the polymer compound of the present invention is obtained by mixing and copolymerizing the monomers (A) and (C) in a specific ratio with respect to the total amount of the monomers (100% by mass). It is. Therefore, the content of the structural unit composed of each monomer in the copolymer of the present invention is the same as the compounding amount of each monomer at the time of copolymerization.
  • the (A) monomer used in the present invention includes (A-1) a monomer having a tertiary amino group represented by the above general formula (1) and Z or (A-2) It has a quaternary ammonium group represented by the formula (2).
  • R 1 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • R 2 and R 3 are each independently a hydrogen atom or a straight chain having 14 carbon atoms.
  • R 4 and R 5 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms
  • m is 0, 1 or 2.
  • Examples of the linear or branched alkyl group having 14 to 14 carbon atoms include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a t-butyl group and an isobutyl group.
  • R 6 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • R 7 and R 8 are independently a hydrogen atom or a carbon atom
  • R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms
  • n is 0, 1 or 2
  • X is , Halogen, OH, 1 / 2SO
  • monomers having a tertiary amino group include dimethylaminoethyl (meth) acrylate (hereinafter, (meth) acryl represents acryl and methacryl), and (meth) (Meth) acrylic acid such as getylaminoethyl acrylate, dipropylaminoethyl (meth) acrylate
  • (meth) acryl represents acryl and methacryl
  • (meth) (Meth) acrylic acid such as getylaminoethyl acrylate, dipropylaminoethyl (meth) acrylate
  • Dialkylaminoalkyl compounds, dimethylaminoethyl (meth) acrylamide, dimethylalkylaminoalkyl (meth) acrylamidide conjugates and the like are preferred, and dimethylaminoethyl (meth) acrylate, getylamino (meth) acrylate are preferred.
  • Ethyl, dialkylaminoalkyl (meth) acrylates such as dipropylaminoethyl (meth) acrylate, dimethylaminoethyl (meth) acrylamide, dimethylaminopropyl (meth) acrylamide, getylaminopropyl (meth) acrylamide And more preferably dimethylaminoethyl (meth) acrylate, getylaminoethyl (meth) acrylate, and dimethylaminopropyl (meth) acrylamide. And methylaminopropyl (meth) acrylamide.
  • A-2 As monomers having a quaternary ammonium group, dimethylaminoethyl methyl chloride (meth) acrylate, dimethylaminoethyl ethyl chloride (meth) acrylate, dimethylamino (meth) acrylate Ethyl ethyl sulfate, dimethylaminoethyl methyl methacrylate (meth) acrylate, dimethylaminoethylethyl methacrylate (meth) acrylate, ethylaminoethyl methyl methacrylate, getylamino methacrylate Ethylethyl chloride, getylaminoethylethyl methacrylate (meth) acrylate, getylaminoethylmethyl phosphate (meth) acrylate, getylaminoethylethyl phosphate (meth) acrylate, dimethylaminopropyl (meth)
  • the monomer (A-1) and the monomer (A-2) may be used alone or in combination. These monomers can be used alone or in an appropriate combination of two or more. In the present invention, it is preferable to use one or more (A-1) monomers in view of the ease of preparation and durability of the composition.
  • the content of the monomer (A) is in the following range. (A) If the content of the monomer is too large, the solubility in water is high, so that the performance in the low-concentration treatment and the one-hour treatment with low durability is deteriorated. On the other hand, if the content of the monomer (A) is too small, the monomer (A) does not function as an adsorption site in the polymer compound, and the low-concentration treatment and the single-hour treatment, which have poor durability, cannot be performed. Performance is reduced.
  • (A-1) When a monomer having a tertiary amino group is contained, its content is 0.1 to 75% by mass, preferably 2-55% by mass, more preferably 2 to 55% by mass of all monomers. Is 3-35% by mass.
  • (A-2) When a monomer having a quaternary ammonium group is contained, its content is 0.1 to 7% by mass, preferably 0.5 to 6% by mass in the whole monomer. %, More preferably 115% by mass.
  • the (B) monomer used in the present invention is a (meth) acrylate ester monomer represented by the following general formula (3).
  • R 12 is a hydrogen atom or a methyl group
  • R 13 is a linear or branched alkyl group having 116, preferably 114 carbon atoms. is there.
  • (B) monomer methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, isopropyl (meth) acrylate, (meth) Butyl acrylate, t-butyl (meth) acrylate, isobutyl (meth) acrylate, hexyl (meth) acrylate and the like.
  • methacrylic acid is preferably methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, isopropyl (meth) acrylate, butyl (meth) acrylate, and t-butyl (meth) acrylate.
  • Methyl acrylate, ethyl methacrylate, propyl methacrylate, isopropyl methacrylate, butyl methacrylate, and t-butyl methacrylate are more preferred. These may be used alone or in an appropriate combination of two or more.
  • the content of the monomer (B) is 21 to 80% by mass, preferably 22 to 55% by mass, and particularly preferably 23 to 50% by mass based on all the monomers. (B) If the content of the monomer is less than 21% by mass, the ability to prevent protein adhesion by low-concentration treatment and short-time treatment decreases, and if it exceeds 80% by mass, it is difficult to obtain uniform solubility.
  • the (C) monomer used in the present invention is a nonionic water-soluble monomer other than the (A) and (B) monomers.
  • the water solubility of the polymer compound can be improved without lowering the ability to prevent protein adhesion.
  • problems such as precipitation of insolubles can be prevented.
  • (C) Monomers include (meth) acrylamide, dimethyl (meth) acrylamide, N-butyl
  • R is a hydrogen atom or a methyl group
  • R 15 is a hydrogen atom, an alkyl group having 1 to 14 carbon atoms or a phenyl group.
  • P is an integer of 2 to 4
  • q is 2 — 250, and there may be two or more alkylene oxide groups with different p in the molecule.
  • Examples of the polyalkylene oxide group-containing monomer represented by the general formula (4) include polyalkylene glycol mono (meth) acrylates, polyethylene glycol polypropylene glycol mono (meth) acrylates, and the like.
  • the (C) monomer is (meth) acrylamide, N-butyl-2-pyrrolidone, methoxypolyethylene glycol mono (meth) atalylate, and more preferably N-butyl 2 —Methoxypolyethylene glycol with an average number of repetitions of 2 to 25 for pyrrolidone and (CHO)
  • the monomer (C) is not limited to the above compounds, and may be used alone or in combination of two or more.
  • the content of the monomer (C) is 0.1 to 78.9% by mass, preferably 15 to 73% by mass, more preferably 30 to 65% by mass, based on all the monomers. . (C) If the content of the monomer is too small, the water solubility is reduced, and if the content is too large, the adsorptivity to the target surface is poor.
  • the polymer compound of the present invention has a weight average molecular weight of 5,000-1,000,000, preferably ⁇ 10,000-500,000, and more preferably ⁇ 10,000-400, 000. If the weight average molecular weight is too small, for example, when used on a gel surface, it will be smaller than its pore size, and if it is too large, the viscosity of the polymer compound solution will be too high, thus limiting the design of the formulation.
  • the method for producing the polymer compound of the present invention is not particularly limited as long as a copolymer obtained by copolymerizing the above ( ⁇ ⁇ )-(C) monomers can be produced.
  • examples thereof include solution polymerization, suspension polymerization, and bulk polymerization. Can be polymerized. Industrially, a method based on solution polymerization is preferred, even though radical polymerization based on solution polymerization or suspension polymerization is preferred.
  • the copolymer of the present invention may be a random copolymer or a block copolymer.
  • examples of the solvent include water, lower alcohols such as methyl alcohol, ethyl alcohol, and isopropyl alcohol; aromatics such as benzene, toluene, xylene, cyclohexane, and hexane; Alternatively, various organic solvents such as heterocyclic compounds, ethyl acetate, acetone, and methyl ethyl ketone can be used.
  • the polymerization concentration is not particularly limited, it is usually preferable to carry out the polymerization at 10 to 50% by mass.
  • polymerization initiator examples include persulfates such as ammonium persulfate, sodium persulfate, and persulfuric acid potassium, peroxides such as benzoyl peroxide and lauroyl peroxide, cumenehydroxide, and the like. Examples thereof include a peroxide at the mouth such as a peroxide at the mouth, and an azoi conjugate such as azobis isopti-tolyl.
  • a chain transfer agent such as an alkyl mercaptan, a polymerization accelerator such as a Lewis acid compound, and a pH adjuster such as phosphoric acid, citric acid, tartaric acid, and lactic acid may be used.
  • the polymerization temperature is appropriately determined depending on the solvent and the polymerization initiator to be used, but usually, the room temperature is preferably 150 ° C.
  • Low molecular weight impurities such as residual monomers contained in the obtained polymer compound can be removed and purified by treatment using activated carbon, ultrafiltration, a dialysis membrane or the like.
  • activated carbon include commonly used wood, coal, coconut shells and the like activated with chemicals and steam, and the shape of the activated carbon is also powder, crushed, fibrous, etc. Not limited.
  • As the material of the ultrafiltration membrane polysulfone, polyethersulfone, polyvinylidene difluoride, cellulose acetate, nitrocellulose and the like can be used.
  • the shape may be a flat membrane shape, a hollow fiber shape or the like, but is not particularly limited.
  • the polymer compound for preventing protein adhesion of the present invention is used as a material for medical devices and the like, and the biocompatibility of the material is degraded by the attachment of a biological substance represented by a protein. It has excellent anti-protein-adhesion ability even at low concentration for a single hour on hard surfaces such as glass, ceramics, stainless steel, and plastic, soft surfaces such as hair and fibers, gel surfaces, and contact lens surfaces. Have.
  • the polymer compound is adsorbed on these surfaces to impart antifouling properties, and is not easily washed away by rinsing with water, so that it can be used as an antifouling composition. In addition, the object can be washed and imparted with antifouling properties.
  • the polymer compound is not washed away by the rinsing, but is adsorbed on the object surface. Since the antifouling agent exhibits antifouling properties, it can be used for a cleaning antifouling agent composition.
  • the composition containing the polymer compound for preventing protein adhesion of the present invention is suitable as an ophthalmic composition because of having the above-mentioned properties, and is particularly suitable as a contact lens.
  • the ophthalmic composition include general eye drops, antibacterial eye drops, artificial tears, contact lens mounting solutions, eyewashes, and the like.
  • Specific examples of the contact lens composition include a treatment solution for a contact lens, a cleaning solution, a preservative solution, a cleaning preservative solution, a cleaning disinfecting solution, and the like.
  • the content of the polymer compound of the present invention in each of the above compositions is not particularly limited, but is usually 0.0001 to 20% by mass, preferably 0.001% by mass based on the whole of each composition. One 10% by mass, more preferably 0.005-5% by mass. If the content of the polymer compound is too small, its function may not be sufficiently exhibited, and if it is too large, there may be a limitation in formulation design.
  • an aionic, cationic, nonionic or amphoteric low-molecular-weight surfactant may be used alone or in accordance with the intended use. Two or more kinds may be used in combination.
  • low molecular weight surfactants examples include alkylbenzene sulfonate, alkyl polyoxyethylene sulfate, alkyl polyoxyethylene ether, fatty acid diethanolamide, N alkylene betaine, polyoxyethylene hydrogenated castor oil 60 (for example, polyoxyethylene oxocystearate tridalicelide such as HCO-60, manufactured by Nippon Surfatatanto Kogyo Co., Ltd., and polyoxymonooleate polyoxylates, such as polysoribate 80 (for example, TO 10M, manufactured by Nippon Surfatatanto Kogyo Co., Ltd.). Ethylene sonorevitan, polyoxyethylene polyoxypropylene block polymer, poloxamine (for example, TETRONIC1107, BASF Japan Ltd.) and the like.
  • polyoxyethylene hydrogenated castor oil 60 For example, polyoxyethylene oxocystearate tridalicelide such as HCO-60, manufactured by Nippon Surfatatanto
  • compositions may include one kind of disinfectant, preservative, enzyme, buffer, stabilizer, isotonic sizing agent, solubilizer, freshener, thickener, and the like. They may be used alone or in combination of two or more.
  • examples of the disinfectant include polyhexamethylene biguanide hydrochloride, Shiridani polydrodium, and the like.
  • As preservatives Shiridani benzalco-pam, Shiridani cetyl pyrididium, sorbic acid, potassium sorbate, methyl noroxybenzoate, ethyl parahydroxybenzoate, propyl nonoxybenzoate, propyloxybenzoate Butyl and the like.
  • Enzymes include trypsin, chymotrypsin, pandaleatin, papain, colavenase, promelain, aminopeptidase, aspergillus peptidase, pronase E, dispase, subtilisin A, subtilisin B, lipase, dalcosidase, mutanase, ⁇ -amylase, dextra And the like.
  • Buffers include boric acid, borax, trometamol, sodium dihydrogen phosphate, disodium hydrogen phosphate, citric acid, sodium citrate, sodium hydrogen carbonate, sodium carbonate, potassium L-aspartate, epsilon-aminocapri Acid, sodium glutamate and the like.
  • ⁇ -cyclodextrin Sodium edetate, sodium bisulfite, sodium thiosulfate and the like.
  • isotonic sizing agent include aminoethylsulfonic acid, potassium sulphite, sodium chloride, sulphite calcium, glycerin, glucose, D-mantol and the like.
  • solubilizers include ethanol, urea, propylene glycol, polyethylene glycol such as Magrogol 4000, and monoethanolamine.
  • fresheners include fennel oil, dl camphor, gerol, heart-strength oil, bergamot oil, d-borneol, 1 menthol, eucalyptus oil and the like.
  • thickener examples include sodium chondroitin sulfate, hyaluronic acid and salts thereof, dextran 70, hydroxycellulose, polyvinyl alcohol, polyvinyl pyrrolidone and the like. If necessary, a lower alcohol, an antibacterial agent, a dye, a fragrance and the like can be used alone or in an appropriate combination of two or more.
  • the composition containing the polymer compound of the present invention is used as a material for medical devices and the like, and the biocompatibility of the material is deteriorated due to the attachment of a biological substance represented by a protein.
  • a water-soluble polymer compound may be added. May be preferred.
  • the combination of the polymer compound of the present invention and a water-soluble polymer compound reduces friction during scrubbing, for example, and better prevents damage to the object. be able to.
  • water-soluble polymer compound examples include cellulosic polymer compounds such as hydroxycellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, and methylcellulose; and polybutyl such as polybutyl alcohol, polybutylpyrrolidone, and carboxybutyl polymer.
  • cellulosic polymer compounds such as hydroxycellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, and methylcellulose
  • polybutyl such as polybutyl alcohol, polybutylpyrrolidone, and carboxybutyl polymer.
  • mucopolysaccharides such as a series polymer compound, sodium chondroitin sulfate, and hyaluronic acid, polyethylene glycol, and dextran.
  • preferred water-soluble high-molecular compounds are cellulose-based polymer compounds, polyvinyl-based polymer compounds, polyethylene render glycols, and hyaluronic acid, and particularly preferred compounds are hydroxypropyl methinoresenolerose, hydroxyethenoresenorelose, and polyvinyl alcohol. Noreanolone, polyvinylinolepyrrolidone, polyethylene glycol and hyaluronic acid.
  • the amount of the water-soluble polymer compound to be added is not particularly limited! 0. for the entire Narubutsu 0001- 20 mass 0/0, preferably from 0.5 001 10 mass 0/0, more rather preferably is 0.5 005- 5 wt%. If the amount of the water-soluble polymer compound is too small, the object may be damaged due to friction when the target surface is scrubbed.If the amount is too large, the viscosity becomes too high and there is a restriction in the formulation design. There are cases.
  • each composition of the present invention are not particularly limited, and each composition can be prepared as a normal dosage form according to a conventional method of each dosage form.
  • each composition can be prepared as a normal dosage form according to a conventional method of each dosage form.
  • DM dimethylaminoethyl methacrylate
  • MMA methyl methacrylate
  • VP bulpyrrolidone
  • Example 1 the types and blending ratios of the monomers were changed so that the compositions shown in Table 1 were obtained. Except for the above, the polymer of Examples 2 to 25 having the composition shown in Table 1 was obtained in the same manner as in Example 1 above.
  • ion-exchanged water was added so that the solid content of the copolymer was 2% by mass, and at the same time, an aqueous solution of hydrochloric acid of 1 mol% L was added to adjust the pH to 6, and a regenerated cellulose dialysis tube (UC36-32-100; Viskase Companies, Inc.) and dialyzed for 1 week while replacing the ion-exchanged water.
  • the aqueous solution containing the polymer compound in the tube was dried using a freeze dryer to obtain a polymer compound (purified copolymer) of Example 26 having the composition shown in Table 3.
  • Example 26 except that the kind and the mixing ratio of the monomers were changed so as to obtain the composition shown in Table 3, the composition of Examples 27 to 62 having the composition shown in Table 3 was obtained in the same manner as in Example 26. A molecular compound was obtained.
  • Comparative Example 3-9 having the composition shown in Table 2, the same method as in Example 1 was used, except that the types and the proportions of the monomers were changed so as to obtain the composition shown in Table 2. Minute A child compound was obtained.
  • the antifouling property 1, the antifouling property 2 and the antifouling property 3 in a 0.05% by mass aqueous solution were evaluated according to the following methods. went. Regarding the evaluation of durability, the copolymer of Example 125 above was evaluated with a 0.1% by mass aqueous solution, and that of Comparative Example 119 with a 1.0% by mass aqueous solution according to the following method. went. Further, with respect to the polymer compounds of Examples 26 to 62 and Comparative Example 19, a 0.05% by mass aqueous solution was used.
  • a stainless plate (10 cm ⁇ 10 cm) was immersed in 500 mL of a 0.05% by mass polymer solution or dispersion for 1 hour at room temperature. Remove the stainless steel plate, rinse with ion-exchanged water, absorb moisture with clean soft paper, immerse the stainless steel plate in a solution of 0.60 g of fibrinogen, a kind of protein, in 500 mL of ion-exchanged water, The mixture was heated and shaken at 30 ° C for 1 hour. The stainless steel plate was removed and water was absorbed with clean soft paper. The stainless plate was stained with fibrinogen attached to the stainless plate using a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
  • Intense staining (corresponds to the colored state when a stainless steel plate is not treated with a polymer compound solution but is brought into contact with a fibrinogen solution and a -hydrin indicator is used)
  • EMAA ethylene methacrylic acid polymer resin (10 cmX IOcm) (Mitsui DuPont Polychemical Co., Ltd.) concentration. It was immersed in 500 mL of a 0.05% by mass polymer solution or dispersion at room temperature for 1 hour. Take out the EMAA fat and rinse with ion exchanged water, clean and soft Egg white lysozyme solution (a type of protein) made by absorbing and absorbing moisture with paper (manufactured by Wako Pure Chemical Industries, Ltd.)
  • EMAA resin was immersed in a solution of 0.60 g in 500 mL of ion-exchanged water, and heated and shaken at 30 ° C for 1 hour. The EMAA ⁇ fat was removed and water was absorbed with clean soft paper. This EMAA resin was stained for lysozyme attached to the EMAA resin using a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
  • EMAA resin was replaced with a soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co.)], and 0.05% by mass of Eris mouth was used as a lysozyme stain.
  • the egg white lysozyme adhered to the soft contact lens was stained in the same manner as in the evaluation method of the antifouling property 2 except that the aqueous solution of syn was used, and the state of color development was evaluated according to the following evaluation criteria.
  • the soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co., Ltd.)] was added to the polymer compound solution of Example 125 and Comparative Example 119 (the polymer compound of Example 125). 1% by mass aqueous solution, Comparative Example 11: High molecular weight compound of 1.0 1.0% by mass aqueous solution) 50 OmU, and immersed at room temperature for 1 hour. Remove the soft contact lens, rinse with ion-exchanged water, absorb the moisture with clean soft paper, and dissolve 0.60 g of egg white lysozyme solution (a product of Wako Pure Chemical Industries, Ltd.) in 500 mL of ion-exchanged water.
  • the mixture After immersing the soft contact lens in the solution, the mixture was heated and shaken at 30 ° C for 15 hours and 30 hours, respectively. I took out the soft contact lens and absorbed the moisture with clean soft paper. For this soft contact lens, lysozyme attached to the lens was stained with a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
  • Intense staining (corresponds to the colored state when a soft contact lens is not treated with a polymer compound solution but is in contact with an egg white lysozyme solution and a -hydrin indicator is used)
  • the soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co., Ltd.)] was used as the polymer compound solution of the above Examples 26-62 and Comparative Example 119 (polymer compound concentration: 0.05% by mass, (0.9% by mass of sodium) in 4 mL at room temperature for 4 hours.
  • the soft contact lens was taken out, rinsed with ion-exchanged water, and wiped clean and soft with paper.
  • the soft contact lenses egg white (manufactured by Wako Pure Chemical Co.) Lysozyme 0.12 mass 0/0, bovine blood Kiyoshi albumin 0.388 mass 0/0 (fraction V, Nacalai Tester Co.), .gamma.
  • globulin 0.161 mass 0/0 bovine, Cohn F- 2, Nacalai tester Co.
  • egg white were mixed Shioi ⁇ sodium 0.9 wt% and disodium hydrogen phosphate 0.045 mass 0/0 It was immersed in 2 mL of lysozyme solution and heated and shaken at 37 ° C for 1 hour. Take out the soft contact lens, clean and soft Moistened paper with a wet paper. With respect to this soft contact lens, a protein attached to the lens was stained with a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
  • Intense staining (corresponds to the colored state when a soft contact lens is not treated with a polymer compound solution but is in contact with an egg white lysozyme solution and a -hydrin indicator is used)
  • a soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson)] was rinsed with ion-exchanged water, and moisture was absorbed with clean soft paper. 0.12% by mass of egg white lysozyme (manufactured by Wako Pure Chemical Industries, Ltd.), 0.388% by mass of bovine serum albumin 0 / "fraction V, manufactured by Nakarai Testa Co., Ltd.” 161 mass 0/0 (bovine, cohn F- 2, Nacalai tester Co.), dipped in egg white lysozyme solution 2mL were mixed Shioi ⁇ sodium 0.9 wt% and disodium hydrogen 0.045 wt% phosphoric acid After heating and shaking for 1 hour at 37 ° C, the soft contact lens was taken out, the moisture was absorbed with clean soft paper, and then the polymer solution of Examples 26-62 and Comparative Example 19-19 was obtained.
  • An antifouling agent composition and an antifouling cleaning composition were prepared according to a conventional method according to the compositions shown in Table 5.
  • the obtained antifouling agent composition and antifouling detergent composition were subjected to the above-mentioned method for evaluating antifouling property 3 by adding 0.05% by mass of a polymer compound solution or dispersion to the antifouling agent composition and the antifouling composition. Evaluation was made in the same manner except that the composition was changed to a soil cleaning composition. The results are shown in Table 5.
  • Example 1 0.03--Example 2 0.03-Polymer-Example 3-0.03-Compound Example 55-0.03
  • Comparative Example 1 ⁇ L0 Comparative Example 2 ⁇ ⁇ 1.0 Polyhexamethylene biguanide hydrochloride 0.0001 0.00007 0.0001 0.0001 ⁇ Polydmium chloride 0.011 ⁇ 0.011
  • TETORONIC 1107 Poloxamine (manufactured by BASF Japan Ltd.)
  • New Pole PE68 Pull mouth nick type nonionic surfactant (manufactured by Sanyo Chemical Co., Ltd.)
  • a polymer compound for preventing protein adhesion which is obtained by copolymerizing the following (A), (B) and (C) and has a weight average molecular weight of 5,000 to 1,000,000, 000.
  • R 1 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • RR 3 is independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms
  • R 4 and R 5 are Independently, it represents a linear or branched alkyl group having 1 to 4 carbon atoms
  • m is 0, 1 or 2.
  • R 6 is a hydrogen atom or a methyl group
  • A is an oxygen atom or NH
  • R 7 and R 8 are each independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms
  • R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms
  • n is 0, 1 or 2
  • X is halogen, OH, 1 / 2SO, HSO, 1 / 3 Indicates PO, HCO or CH CO.
  • R 12 is a hydrogen atom or a methyl group
  • R 13 is a linear or branched chain having 16 carbon atoms. Is an alkyl group.
  • An antifouling composition comprising the polymer compound according to claim 1.
  • a cleaning antifouling composition comprising the polymer compound according to claim 1.
  • An ophthalmic composition comprising the polymer compound according to claim 1.
  • a composition for a contact lens comprising the polymer compound according to claim 1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Detergent Compositions (AREA)
  • Eyeglasses (AREA)

Abstract

[MEANS FOR SOLVING PROBLEMS] A polymer for preventing protein adhesion obtained by copolymerizing a monomer having a specific tertiary amino group and/or a monomer having a specific quaternary ammonium group with a (meth)acrylic ester monomer and a nonionic water-soluble monomer in specific amounts. [EFFECTS] The polymer for preventing protein adhesion, even when used in a low-concentration short-time treatment, has the excellent long-lasting ability to prevent protein from adhering to hard surfaces of, e.g., glasses, ceramics, stainless steel, and plastics, soft surfaces of, e.g., hairs and fibers, gel surfaces, and contact lens surfaces.

Description

明 細 書  Specification
タンパク質付着防止用高分子化合物及びこれを含有する組成物 技術分野  TECHNICAL FIELD The present invention relates to a polymer compound for preventing protein adhesion and a composition containing the same.
[0001] 本発明は、優れたタンパク質付着防止能を有するタンパク質付着防止用高分子化 合物、これを含有してなる組成物に関する。さらに詳しくは、医療用具等の材料として 使用され、タンパク質に代表されるような生体由来物質が付着することによって材料 の生体適合性が悪ィ匕することが懸念されるガラス、セラミック、ステンレス、プラスチッ ク等の硬表面、毛髪、繊維等の軟表面、及びゲル表面、特にコンタクトレンズ表面に 対して、低濃度かつ短時間処理によっても該表面に吸着し、耐久性があり優れたタン パク質付着防止能を付与するタンパク質付着防止用高分子化合物及び該高分子化 合物を含有する組成物に関する。  The present invention relates to a polymer compound for preventing protein adhesion having an excellent ability to prevent protein adhesion, and a composition containing the same. More specifically, glass, ceramic, stainless steel, plastic, and the like, which are used as materials for medical devices and the like, and there is a concern that the biocompatibility of the material may be impaired by the attachment of biological substances such as proteins. Adhesion to hard surfaces such as skin, soft surfaces such as hair and fibers, and gel surfaces, especially contact lens surfaces, even when treated at low concentration and for a short time, and durable and excellent protein adhesion The present invention relates to a polymer compound for preventing protein adhesion imparting a protective ability and a composition containing the polymer compound.
背景技術  Background art
[0002] 医療用具等の材料として使用され、タンパク質に代表されるような生体由来物質が 付着することによって材料の生体適合性が悪ィ匕することが懸念されるものとして、ガラ ス、セラミック、ステンレス、各種プラスチック等の硬表面、毛髪、繊維といった軟表面 、あるいはゲル表面、コンタクトレンズ表面等が挙げられる。このようなものは、特殊な 有機溶剤と接触すると簡単に表面を痛めてしまうものが多い。これらの表面を処理す る表面処理剤としては、水溶性タイプの商品が望まれている。また、表面処理剤は、 通常の使用によって、接触する水や濯ぎ水等で簡単に処理剤が取れな!/ヽような耐久 性があり、かつ使用性の点力 短時間処理やできるだけ低濃度の処理剤によっても 良好な効果が得られるものが望まれている。さらに、人体が接触する用途に対しては 、安全性が考慮されているものが望まれている。  [0002] Glass, ceramics, ceramics, and the like are used as materials for medical devices and the like, and there is a concern that the biocompatibility of the material may be degraded due to the attachment of a biological substance represented by a protein. Examples include hard surfaces of stainless steel and various plastics, soft surfaces such as hair and fibers, gel surfaces, contact lens surfaces, and the like. In many cases, such substances easily damage the surface when they come into contact with special organic solvents. As surface treating agents for treating these surfaces, products of a water-soluble type are desired. In addition, the surface treatment agent cannot be easily removed with the water or rinsing water that comes into contact with normal use! It is desired to have durability that is as long as possible, and that the good effect can be obtained even with a short-time treatment or a treatment agent with the lowest possible concentration. Further, for applications in which the human body comes into contact, it is desired that safety is considered.
[0003] 表面処理剤としては、 3級アミノ基を含有する高分子化合物、洗浄剤組成物、防汚 剤組成物及び洗浄性防汚剤組成物が提案されて ヽる (例えば、特許文献 1:特開 20 02— 256030号公報参照)。具体的には、ポリオキシアルキレンオキサイドを含有す るモノマーを必須成分とする高分子化合物力 なることを特徴とするもので、コンタク トレンズ用洗浄剤に含有させることにより涙液由来のタンパク質の汚れ防止効果に優 れるものである。しかし、タンパク質汚れに限った場合、長期間使用中に被覆表面か ら洗い流されず残るような耐久性について、さらなる効果が望まれていた。また、様々 な汚染物質に対して付着防止性に優れているものの、タンパク質付着防止に対して 、短時間処理や低濃度の高分子化合物溶液処理でさらなる効果が望まれて!/、た。 [0003] As a surface treatment agent, a polymer compound containing a tertiary amino group, a detergent composition, an antifouling agent composition, and a cleaning antifouling agent composition have been proposed (for example, Patent Document 1). : See JP-A-2002-256030). Specifically, it is a polymer compound containing a polyoxyalkylene oxide-containing monomer as an essential component, and contains a detergent for contact lenses to prevent contamination of tear-derived proteins. Excellent effect It is what is done. However, in the case of protein stains only, a further effect has been desired with respect to durability such that it remains without being washed off from the coated surface during long-term use. In addition, although it has excellent anti-adhesion properties against various contaminants, it is desired to further prevent protein adhesion by short-time treatment or low-concentration polymer compound solution treatment!
[0004] また、コンタクトレンズへの汚れ付着防止技術として、 4級ァミン官能性基を 10— 45 mol%有する高分子化合物が提案されて 、る(例えば特許文献 2:特表 2000 - 510 186号公報参照)。具体的にはコンタクトレンズへのタンパク質の蓄積を阻害する組 成物及び方法が提案されている。しかしながら、 4級ァミン官能性基の含有率が高す ぎるために、本発明が目的とするタンパク質付着防止に関して、短時間処理や低濃 度の高分子化合物溶液処理によっては、該表面に吸着して優れたタンパク質付着防 止能を付与する機能は得られな 、。  [0004] As a technique for preventing adhesion of dirt to contact lenses, a polymer compound having a quaternary amine functional group in an amount of 10 to 45 mol% has been proposed (for example, Patent Document 2: JP-T-2000-510186). Gazette). Specifically, compositions and methods for inhibiting the accumulation of proteins in contact lenses have been proposed. However, since the content of the quaternary amine functional group is too high, in order to prevent protein adhesion, which is the object of the present invention, it may be adsorbed on the surface by short-time treatment or treatment with a low-concentration polymer solution. And a function of imparting an excellent protein adhesion prevention ability cannot be obtained.
[0005] 一方、イオン性を有するコンタクトレンズ用途の高分子化合物が提案されて!ヽる(例 えば特許文献 3 :特開昭 54— 116947号公報参照)。具体的には、主にイオン性コン タ外レンズの表面を表面と反対の電荷をもつ水保持能が高い高分子化合物で被覆 することにより、表面の潤いを高くする組成物及び方法が提案されている。し力しなが ら、本発明が目的とするタンパク質付着防止に関して、短時間処理や低濃度の高分 子化合物溶液処理によっても該表面に吸着して優れたタンパク質付着防止能を付 与する機能は得られない。  [0005] On the other hand, ionic polymer compounds for use in contact lenses have been proposed (see, for example, Patent Document 3: JP-A-54-116947). Specifically, a composition and a method have been proposed which increase the surface moisture by coating the surface of the ionic contour lens with a polymer compound having a charge opposite to that of the surface and having a high water retention ability. ing. However, with regard to the prevention of protein adhesion targeted by the present invention, the function of adsorbing to the surface even by short-time treatment or treatment with a low-concentration polymer compound solution to impart excellent protein adhesion prevention ability. Cannot be obtained.
[0006] さらに、ビニルポリマーのカチオン性誘導体を有する高分子化合物が提案され (特 許文献 4 :特開平 1 50014号公報参照)、高分子化合物によりレンズを親水化する ことで脂質汚れが付着しにくい組成物及び方法が開示されているが、本発明が目的 とするタンパク質付着防止に関して、短時間処理や低濃度の高分子化合物溶液処 理によっても該表面に吸着して優れたタンパク質付着防止を付与する機能は得られ ない。  [0006] Furthermore, a polymer compound having a cationic derivative of a vinyl polymer has been proposed (Patent Document 4: Japanese Patent Application Laid-Open No. 150014/1993), and lipid dirt adheres by making the lens hydrophilic with the polymer compound. Although difficult compositions and methods have been disclosed, the present invention aims to prevent protein adhesion by adsorbing to the surface even by short-time treatment or treatment with a low-concentration polymer compound solution. The function to be given cannot be obtained.
[0007] 特許文献 1:特開 2002— 256030号公報  [0007] Patent Document 1: Japanese Patent Application Laid-Open No. 2002-256030
特許文献 2 :特表 2000— 510186号公報  Patent Document 2: JP-T-2000-510186
特許文献 3:特開昭 54 - 116947号公報  Patent Document 3: JP-A-54-116947
特許文献 4 :特開平 1-50014号公報 発明の開示 Patent Document 4: JP-A-1-50014 Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0008] 本発明は上記事情に鑑みなされたもので、医療用具等の材料として使用されてお り、タンパク質に代表されるような生体由来物質が付着することによって材料の生体 適合性が悪ィ匕することが懸念されるガラスやセラミック、ステンレス、プラスチック等の 硬表面、毛髪、繊維等の軟表面、ゲル表面及びコンタクトレンズ表面等に対して、低 濃度かつ短時間処理によっても優れたタンパク質付着防止能を有し、かつその防止 能が耐久性に優れたタンパク質付着防止用高分子化合物を提供することを目的とす る。さらに、水での濯ぎによっても簡単に流されず、対象面に吸着して防汚性を発現 する防汚剤組成物、洗浄と同時に防汚性を有する洗浄性防汚剤組成物、眼科用組 成物及びコンタクトレンズ用組成物を提供することを目的とする。  [0008] The present invention has been made in view of the above circumstances, and is used as a material for medical devices and the like, and the biocompatibility of the material is poor due to the attachment of a biological substance such as a protein. Excellent protein adherence to hard surfaces such as glass, ceramics, stainless steel, and plastics, soft surfaces such as hair and fibers, gel surfaces, and contact lens surfaces, etc., which may cause danger, even when treated at low concentration and for a short time. An object of the present invention is to provide a polymer compound for preventing protein adhesion, which has an inhibitory ability and has an excellent durability. Furthermore, an antifouling agent composition that is not easily washed away even by rinsing with water and is adsorbed on the target surface and exhibits antifouling properties, a cleaning antifouling composition that has antifouling properties simultaneously with cleaning, and ophthalmic use It is intended to provide compositions and compositions for contact lenses.
課題を解決するための手段  Means for solving the problem
[0009] 本発明者は、上記目的を達成するため鋭意検討した結果、特定の 3級アミノ基を有 する単量体及び Z又は特定の 4級アンモニゥム基を有する単量体と、(メタ)アクリル 酸エステル単量体と、ノニオン性水溶性単量体とを特定量で共重合させてなり、重量 平均分子量が 5, 000— 1, 000, 000である高分子化合物力 上記硬表面、軟表面 、ゲル表面に対して、低濃度かつ短時間処理によっても、耐久性のあるタンパク付着 防止能を有することを知見した。さらに鋭意検討した結果、上記高分子化合物を水 溶性組成物中に含有させることにより、低濃度かつ短時間処理によっても、対象面に 吸着して優れたタンパク質付着防止能を有し、水での濯ぎを伴うような洗浄工程にお いて上記共重合体が洗い流されず、有効成分として対象面に吸着して防汚性を発 現することを知見し、本発明をなすに至ったものである。  As a result of intensive studies to achieve the above object, the present inventors have found that a monomer having a specific tertiary amino group and a monomer having Z or a specific quaternary ammonium group, A polymer compound obtained by copolymerizing an acrylic acid ester monomer and a nonionic water-soluble monomer in a specific amount and having a weight average molecular weight of 5,000 to 1,000,000. It has been found that even when the surface and the gel surface are treated at a low concentration for a short time, the gel has a durable protein adhesion preventing ability. As a result of further intensive studies, it was found that the inclusion of the above-mentioned polymer compound in the water-soluble composition allows it to be adsorbed on the target surface even at low concentration and for a short period of time, and has an excellent ability to prevent protein adhesion. The present inventors have found that the copolymer is not washed out in a washing step involving rinsing, and is adsorbed on an object surface as an active ingredient to exhibit antifouling properties, and the present invention has been accomplished.
[0010] 従って、本発明は、下記 (A)、(B)及び (C)を共重合してなり、重量平均分子量が Therefore, the present invention is obtained by copolymerizing the following (A), (B) and (C), and has a weight average molecular weight
5, 000— 1, 000, 000であるタンパク質付着防止用高分子化合物、並びにこの高 分子化合物を含有してなる防汚剤組成物、洗浄性防汚剤組成物、眼科用組成物及 びコンタクトレンズ用組成物を提供する。 A polymer compound for preventing protein adhesion of 5,000 to 1,000,000, and an antifouling agent composition, a cleaning antifouling agent composition, an ophthalmic composition, and a contact containing the high molecular compound A composition for a lens is provided.
(A) (A— 1)下記一般式(1)で表される 3級アミノ基を有する単量体 0. 1— 75質量% 及び Z又は (A - 2)下記一般式(2)で表される 4級アンモニゥム基を有する単量体 0 [0011] [化 1] (A) (A-1) 0.1 to 75% by mass of a monomer having a tertiary amino group represented by the following general formula (1) and Z or (A-2) represented by the following general formula (2) Monomer having a quaternary ammonium group 0 [0011] [Formula 1]
(1)
Figure imgf000006_0001
(1)
Figure imgf000006_0001
(式中、 R1は水素原子又はメチル基、 Aは酸素原子又は NH、 R R3は独立に、水素 原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基、 R4、 R5は独立に、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示し、 mは 0、 1又は 2である。 ) (Wherein, R 1 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, RR 3 is independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms, and R 4 and R 5 are Independently, it represents a linear or branched alkyl group having 1 to 4 carbon atoms, and m is 0, 1 or 2.)
[化 2]  [Formula 2]
Figure imgf000006_0002
Figure imgf000006_0002
(式中、 R6は水素原子又はメチル基、 Aは酸素原子又は NH、 R7、 R8は独立に、水素 原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基、 R9、 R1Q及び R11は独立に 、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示し、 nは 0、 1又は 2、 Xは、ハロ ゲン、 OH、 1/2SO、 HSO、 1/3PO、 HCO又は CH COを示す。) (Wherein, R 6 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, R 7 and R 8 are each independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms, R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms, n is 0, 1 or 2, and X is halogen, OH, 1 / 2SO, HSO, 1 / 3 Indicates PO, HCO or CH CO.)
(B)下記一般式(3)で表される (メタ)アクリル酸エステル単量体 21— 80質量% CH =C (R12) COOR13 (3) (B) (meth) acrylic acid ester monomer represented by the following general formula (3) 21-80% by mass CH = C (R 12 ) COOR 13 (3)
(式中、 R12は水素原子又はメチル基であり、 R13は炭素数 1一 6の直鎖もしくは分岐鎖 のアルキル基である。) (In the formula, R 12 is a hydrogen atom or a methyl group, and R 13 is a linear or branched alkyl group having 16 carbon atoms.)
(C) (A) , (B)単量体以外のノニオン性水溶性単量体 0. 1— 78. 9質量% 発明の効果  (C) Nonionic water-soluble monomers other than (A) and (B) monomers 0.1 to 78.9% by mass Effect of the Invention
[0013] 本発明によれば、医療用具等の材料として使用されて、タンパク質に代表されるよう な生体由来物質が付着することによって材料の生体適合性が悪化することが懸念さ れるガラス、セラミック、ステンレス、プラスチック等の硬表面、毛髪、繊維等の軟表面 、ゲル表面、及びコンタクトレンズ表面に対して、低濃度かつ短時間処理によっても、 耐久性があり優れたタンパク質付着防止能を有し、防汚剤として有用な、タンパク質 付着防止用高分子化合物、これを含有してなる防汚剤組成物、洗浄性防汚剤組成 物、眼科用組成物及びコンタクトレンズ用組成物を提供することができる。 [0013] According to the present invention, there is a concern that the biocompatibility of a material may be deteriorated due to the attachment of a biological substance such as a protein when used as a material for a medical device or the like. Hard surface of steel, stainless steel, plastic etc., soft surface of hair, fiber etc. A polymer compound for preventing protein adhesion, which is durable and has an excellent protein adhesion preventing ability even when treated at a low concentration and for a short time on a gel surface and a contact lens surface, and is useful as an antifouling agent. An antifouling agent composition, a cleaning antifouling agent composition, an ophthalmic composition and a contact lens composition containing the same can be provided.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0014] 以下、本発明につき、さらに詳しく説明する。本発明の高分子化合物は、上記 (A) 一 (C)の単量体を、単量体合計配合量 (100質量%)に対して各単量体を特定割合 で配合し共重合したものである。従って、本発明の共重合体における各単量体から なる構成単位の含有量は、共重合する際の各単量体の配合量と同様である。  Hereinafter, the present invention will be described in more detail. The polymer compound of the present invention is obtained by mixing and copolymerizing the monomers (A) and (C) in a specific ratio with respect to the total amount of the monomers (100% by mass). It is. Therefore, the content of the structural unit composed of each monomer in the copolymer of the present invention is the same as the compounding amount of each monomer at the time of copolymerization.
[0015] 本発明において用いられる (A)単量体は、(A— 1)上記一般式(1)で表される 3級 アミノ基を有する単量体及び Z又は (A - 2)上記一般式(2)で表される 4級アンモニ ゥム基を有するものである。  [0015] The (A) monomer used in the present invention includes (A-1) a monomer having a tertiary amino group represented by the above general formula (1) and Z or (A-2) It has a quaternary ammonium group represented by the formula (2).
[0016] ここで、上記一般式(1)において、 R1は水素原子又はメチル基、 Aは酸素原子又は NH、 R2、 R3は独立に、水素原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル 基、 R4、 R5は独立に、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示し、 mは 0 、 1又は 2である。炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基としては、メチル基 、ェチル基、プロピル基、イソプロピル基、ブチル基、 t ブチル基、イソブチル基が挙 げられる。 Here, in the general formula (1), R 1 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, R 2 and R 3 are each independently a hydrogen atom or a straight chain having 14 carbon atoms. Alternatively, R 4 and R 5 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms, and m is 0, 1 or 2. Examples of the linear or branched alkyl group having 14 to 14 carbon atoms include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a t-butyl group and an isobutyl group.
[0017] ここで、上記一般式(2)にお 、て、 R6は水素原子又はメチル基、 Aは酸素原子又は NH、 R7、 R8は独立に、水素原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル 基、 R9、 R1Q及び R11は独立に、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示 し、 nは 0、 1又は 2、 Xは、ハロゲン、 OH、 1/2SO In the general formula (2), R 6 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, R 7 and R 8 are independently a hydrogen atom or a carbon atom R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms, n is 0, 1 or 2, and X is , Halogen, OH, 1 / 2SO
4、 HSO  4, HSO
4、 1/3PO  4, 1 / 3PO
4、 HCO又は 2 4, HCO or 2
CH COを示す。炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基としては、メチルIndicates CH CO. As a linear or branched alkyl group having 1 to 4 carbon atoms, methyl
3 2 3 2
基、ェチル基、プロピル基、イソプロピル基、ブチル基、 t ブチル基、イソブチル基が 挙げられる。  Group, ethyl group, propyl group, isopropyl group, butyl group, t-butyl group and isobutyl group.
[0018] (A-1) 3級アミノ基を有する単量体として、より具体的には、(メタ)アクリル酸ジメチ ルアミノエチル (以下、(メタ)アクリルはアクリルとメタクリルを表す)、(メタ)アクリル酸 ジェチルアミノエチル、(メタ)アクリル酸ジプロピルアミノエチル等の(メタ)アクリル酸 ジアルキルアミノアルキル化合物、ジメチルアミノエチル (メタ)アクリルアミド、ジメチル アルキルアミノアルキル (メタ)アクリルアミドィ匕合物等が挙げられ、好ましくは (メタ)ァ クリル酸ジメチルアミノエチル、(メタ)アクリル酸ジェチルアミノエチル、(メタ)アクリル 酸ジプロピルアミノエチル等の(メタ)アクリル酸ジアルキルアミノアルキル化合物、ジ メチルアミノエチル (メタ)アクリルアミド、ジメチルァミノプロピル (メタ)アクリルアミド、 ジェチルァミノプロピル (メタ)アクリルアミド等のジアルキルアミノアルキル (メタ)アタリ ルアミド化合物であり、さらに好ましくは (メタ)アクリル酸ジメチルアミノエチル、(メタ) アクリル酸ジェチルアミノエチル、ジメチルァミノプロピル (メタ)アクリルアミド、ジェチ ルァミノプロピル (メタ)アクリルアミド等である。 (A-1) More specifically, monomers having a tertiary amino group include dimethylaminoethyl (meth) acrylate (hereinafter, (meth) acryl represents acryl and methacryl), and (meth) (Meth) acrylic acid such as getylaminoethyl acrylate, dipropylaminoethyl (meth) acrylate Dialkylaminoalkyl compounds, dimethylaminoethyl (meth) acrylamide, dimethylalkylaminoalkyl (meth) acrylamidide conjugates and the like are preferred, and dimethylaminoethyl (meth) acrylate, getylamino (meth) acrylate are preferred. Ethyl, dialkylaminoalkyl (meth) acrylates such as dipropylaminoethyl (meth) acrylate, dimethylaminoethyl (meth) acrylamide, dimethylaminopropyl (meth) acrylamide, getylaminopropyl (meth) acrylamide And more preferably dimethylaminoethyl (meth) acrylate, getylaminoethyl (meth) acrylate, and dimethylaminopropyl (meth) acrylamide. And methylaminopropyl (meth) acrylamide.
(A— 2) 4級アンモ-ゥム基を有する単量体として、(メタ)アクリル酸ジメチルアミノエ チルメチルクロライド、(メタ)アクリル酸ジメチルアミノエチルェチルクロライド、(メタ) アクリル酸ジメチルアミノエチルェチル硫酸、(メタ)アクリル酸ジメチルアミノエチルメ チルリン酸、(メタ)アクリル酸ジメチルアミノエチルェチルリン酸、(メタ)アクリル酸ジェ チルアミノエチルメチルクロライド、(メタ)アクリル酸ジェチルアミノエチルェチルクロラ イド、(メタ)アクリル酸ジェチルアミノエチルェチル硫酸、(メタ)アクリル酸ジェチルァ ミノェチルメチルリン酸、(メタ)アクリル酸ジェチルアミノエチルェチルリン酸、ジメチ ルァミノプロピル (メタ)アクリルアミドメチルクロライド、ジメチルァミノプロピル (メタ)ァ クリルアミドエチルクロライド、ジメチルァミノプロピル (メタ)アクリルアミドエチル硫酸、 ジメチルァミノプロピル (メタ)アクリルアミドメチルリン酸、ジメチルァミノプロピル (メタ) アクリルアミドエチルリン酸等が挙げられる。この中でも (メタ)アクリル酸ジメチルァミノ ェチルメチルクロライド、(メタ)アクリル酸ジメチルアミノエチルェチルクロライド、(メタ )アクリル酸ジメチルアミノエチルェチル硫酸、(メタ)アクリル酸ジェチルアミノエチル メチルクロライド、(メタ)アクリル酸ジェチルアミノエチルェチルクロライド、(メタ)アタリ ル酸ジェチルアミノエチルェチル硫酸、ジメチルァミノプロピル (メタ)アクリルアミドメ チルクロライド、ジメチルァミノプロピル (メタ)アクリルアミドエチルクロライド、ジメチル ァミノプロピル (メタ)アクリルアミドエチル硫酸が好ましく、(メタ)アクリル酸ジメチルァ ミノェチルメチルクロライド、(メタ)アクリル酸ジメチルアミノエチルェチルクロライド、 ( メタ)アクリル酸ジメチルアミノエチルェチル硫酸がさらに好まし 、。 (A-2) As monomers having a quaternary ammonium group, dimethylaminoethyl methyl chloride (meth) acrylate, dimethylaminoethyl ethyl chloride (meth) acrylate, dimethylamino (meth) acrylate Ethyl ethyl sulfate, dimethylaminoethyl methyl methacrylate (meth) acrylate, dimethylaminoethylethyl methacrylate (meth) acrylate, ethylaminoethyl methyl methacrylate, getylamino methacrylate Ethylethyl chloride, getylaminoethylethyl methacrylate (meth) acrylate, getylaminoethylmethyl phosphate (meth) acrylate, getylaminoethylethyl phosphate (meth) acrylate, dimethylaminopropyl (meth) acrylate ) Acrylamide methyl chloride, dimethylaminopropyl (T) acrylamidoethyl chloride, dimethylaminopropyl (meth) acrylamidoethylsulfate, dimethylaminopropyl (meth) acrylamidomethylphosphoric acid, dimethylaminopropyl (meth) acrylamidoethylphosphoric acid and the like. Among them, dimethylaminoethyl methyl chloride (meth) acrylate, dimethylaminoethylethyl chloride (meth) acrylate, dimethylaminoethylethyl sulphate (meth) acrylate, getylaminoethyl methyl chloride (meth) acrylate, (Meth) acrylic acid ethyl ethyl ethyl chloride, (meth) acrylic acid ethyl ethyl ethyl ethyl sulfate, dimethylaminopropyl (meth) acrylamide methyl chloride, dimethylaminopropyl (meth) acrylamidoethyl chloride, dimethyl Aminopropyl (meth) acrylamidoethyl sulfate is preferred, and dimethylaminoethyl methyl methacrylate, dimethylaminoethyl ethyl methacrylate, Dimethylaminoethylethyl methacrylate) is more preferred.
[0020] (A— 1)単量体と (A— 2)単量体は各々単独で用いてもよいし、併用して用いてもよ い。また、これらの単量体は 1種単独で又は 2種以上を適宜組み合わせて用いること ができる。本発明においては、組成物の作りやすさと耐久性の点から、(A— 1)単量 体を 1種又は 2種以上用いることが好ま U、。  [0020] The monomer (A-1) and the monomer (A-2) may be used alone or in combination. These monomers can be used alone or in an appropriate combination of two or more. In the present invention, it is preferable to use one or more (A-1) monomers in view of the ease of preparation and durability of the composition.
[0021] (A)単量体の含有量は各々下記の範囲である。(A)単量体の含有量が多すぎると 、水への溶解性が高いため、耐久性がなぐ低濃度処理、単時間処理での性能が低 下する。また、(A)単量体の含有量が少なすぎると、(A)単量体が高分子化合物中 で吸着部位としてしつかりと機能せず、耐久性がなぐ低濃度処理及び単時間処理 での性能が低下する。  [0021] The content of the monomer (A) is in the following range. (A) If the content of the monomer is too large, the solubility in water is high, so that the performance in the low-concentration treatment and the one-hour treatment with low durability is deteriorated. On the other hand, if the content of the monomer (A) is too small, the monomer (A) does not function as an adsorption site in the polymer compound, and the low-concentration treatment and the single-hour treatment, which have poor durability, cannot be performed. Performance is reduced.
[0022] (A-1) 3級アミノ基を有する単量体を含有する場合、その含有量は全単量体中に 0 . 1一 75質量%、好ましくは 2— 55質量%、より好ましくは 3— 35質量%である。  (A-1) When a monomer having a tertiary amino group is contained, its content is 0.1 to 75% by mass, preferably 2-55% by mass, more preferably 2 to 55% by mass of all monomers. Is 3-35% by mass.
[0023] (A— 2) 4級アンモ-ゥム基を有する単量体を含有する場合、その含有量は全単量 体中に 0. 1— 7質量%、好ましくは 0. 5— 6質量%、より好ましくは 1一 5質量%であ る。  (A-2) When a monomer having a quaternary ammonium group is contained, its content is 0.1 to 7% by mass, preferably 0.5 to 6% by mass in the whole monomer. %, More preferably 115% by mass.
[0024] 本発明において用いられる(B)単量体は、下記一般式(3)で表される (メタ)アタリ ル酸エステル単量体である。  [0024] The (B) monomer used in the present invention is a (meth) acrylate ester monomer represented by the following general formula (3).
CH =C (R12) COOR13 (3) CH = C (R 12 ) COOR 13 (3)
2  2
[0025] ここで、上記一般式(3)において、 R12は水素原子又はメチル基であり、 R13は炭素 数が 1一 6、好ましくは 1一 4の直鎖もしくは分岐鎖のアルキル基である。 Here, in the general formula (3), R 12 is a hydrogen atom or a methyl group, and R 13 is a linear or branched alkyl group having 116, preferably 114 carbon atoms. is there.
[0026] (B)単量体として、より具体的には、(メタ)アクリル酸メチル、(メタ)アクリル酸ェチ ル、(メタ)アクリル酸プロピル、(メタ)アクリル酸イソプロピル、(メタ)アクリル酸ブチル 、(メタ)アクリル酸 tーブチル、(メタ)アクリル酸イソブチル、(メタ)アクリル酸へキシル 等が挙げられる。この中でも (メタ)アクリル酸メチル、(メタ)アクリル酸ェチル、(メタ) アクリル酸プロピル、(メタ)アクリル酸イソプロピル、(メタ)アクリル酸ブチル、(メタ)ァ クリル酸 t ブチルが好ましぐメタクリル酸メチル、メタクリル酸ェチル、メタクリル酸プ 口ピル、メタクリル酸イソプロピル、メタクリル酸ブチル、メタクリル酸 t ブチルがさらに 好ましい。これらは、 1種単独で又は 2種以上を適宜組み合わせて用いてもよい。 [0027] (B)単量体の含有量は、全単量体中に 21— 80質量%、好ましくは 22— 55質量% 、特に好ましくは 23— 50質量%である。(B)単量体の含有量が 21質量%未満だと 低濃度処理、短時間処理によるタンパク質付着防止能が低下し、 80質量%を超える と均一な溶解性を得ることが難し ヽ。 [0026] More specifically, as the (B) monomer, methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, isopropyl (meth) acrylate, (meth) Butyl acrylate, t-butyl (meth) acrylate, isobutyl (meth) acrylate, hexyl (meth) acrylate and the like. Of these, methacrylic acid is preferably methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, isopropyl (meth) acrylate, butyl (meth) acrylate, and t-butyl (meth) acrylate. Methyl acrylate, ethyl methacrylate, propyl methacrylate, isopropyl methacrylate, butyl methacrylate, and t-butyl methacrylate are more preferred. These may be used alone or in an appropriate combination of two or more. [0027] The content of the monomer (B) is 21 to 80% by mass, preferably 22 to 55% by mass, and particularly preferably 23 to 50% by mass based on all the monomers. (B) If the content of the monomer is less than 21% by mass, the ability to prevent protein adhesion by low-concentration treatment and short-time treatment decreases, and if it exceeds 80% by mass, it is difficult to obtain uniform solubility.
[0028] 本発明にお ヽて用いられる (C)単量体は、 (A) , (B)単量体以外のノニオン性水溶 性単量体である。 (A)及び (B)単量体以外のノニオン性水溶性単量体を共重合する ことにより、タンパク質付着防止能を低下させずに高分子化合物の水溶性を向上さ せることができ、本発明の高分子化合物を含有する組成物にした場合に、不溶物の 析出等の不具合を防ぐことができる。  [0028] The (C) monomer used in the present invention is a nonionic water-soluble monomer other than the (A) and (B) monomers. By copolymerizing a nonionic water-soluble monomer other than the monomers (A) and (B), the water solubility of the polymer compound can be improved without lowering the ability to prevent protein adhesion. When a composition containing the polymer compound of the present invention is used, problems such as precipitation of insolubles can be prevented.
[0029] (C)単量体としては、 (メタ)アクリルアミド、ジメチル (メタ)アクリルアミド、 N-ビュル [0029] (C) Monomers include (meth) acrylamide, dimethyl (meth) acrylamide, N-butyl
2 ピロリドン、糖類縁基含有単量体、下記一般式 (4)で示されるポリアルキレンォ キシド基含有単量体等が挙げられる。  2 Pyrrolidone, a saccharide-related group-containing monomer, a polyalkylene oxide group-containing monomer represented by the following general formula (4), and the like.
CH =C (R14) COO (C H O) R15 (4) CH = C (R 14 ) COO (CHO) R 15 (4)
2 p 2p q  2 p 2p q
(式中、 R"は水素原子又はメチル基であり、 R15は水素原子、炭素数が 1一 4のアル キル基又はフエ-ル基である。 pは 2— 4の整数、 qは 2— 250であり、分子中に pが異 なる 2種以上のアルキレンォキシド基があってもょ 、。 ) (In the formula, R "is a hydrogen atom or a methyl group, R 15 is a hydrogen atom, an alkyl group having 1 to 14 carbon atoms or a phenyl group. P is an integer of 2 to 4, and q is 2 — 250, and there may be two or more alkylene oxide groups with different p in the molecule.)
[0030] 上記一般式 (4)で示されるポリアルキレンォキシド基含有単量体としては、ポリェチ レングリコールモノ(メタ)アタリレート、ポリエチレングリコール ポリプロピレングリコー ルモノ (メタ)アタリレート等のポリアルキレングリコールモノ (メタ)アタリレート、メトキシ ポリエチレングリコールモノ(メタ)アタリレート、メトキシポリエチレングリコールーポリプ ロピレングリコールモノ(メタ)アタリレート、エトキシポリエチレングリコール (メタ)アタリ レート、エトキシポリエチレングリコール ポリプロピレングリコールモノ(メタ)アタリレー ト等のポリアルキレングリコールモノ (メタ)アタリレート等の炭素数 1一 3のアルキル基 でアルコキシ化されたアルコキシポリアルキレングリコールモノ(メタ)アタリレート、フエ ノキシポリエチレングリコールモノ(メタ)アタリレート、フエノキシポリエチレングリコール ポリプロピレングリコールモノ (メタ)アタリレート等が挙げられる。 Examples of the polyalkylene oxide group-containing monomer represented by the general formula (4) include polyalkylene glycol mono (meth) acrylates, polyethylene glycol polypropylene glycol mono (meth) acrylates, and the like. (Meth) acrylate, methoxy polyethylene glycol mono (meth) acrylate, methoxy polyethylene glycol-propylene glycol mono (meth) acrylate, ethoxy polyethylene glycol (meth) acrylate, ethoxy polyethylene glycol polypropylene glycol mono (meth) acrylate , Such as polyalkylene glycol mono (meth) acrylates, etc., alkoxypolyalkylene glycol mono (meth) acrylates alkoxylated with an alkyl group having 13 carbon atoms Over DOO, Hue Roh alkoxy polyethylene glycol mono (meth) Atari rate, phenoxyethanol polyethylene glycol polypropylene glycol mono (meth) Atari rate, and the like.
[0031] 好まし 、 (C)単量体としては、 (メタ)アクリルアミド、 N-ビュル- 2—ピロリドン、メトキ シポリエチレングリコールモノ (メタ)アタリレートであり、さらに好ましくは N ビュル 2 —ピロリドン、 (C H O)の平均繰り返し数が 2— 25のメトキシポリエチレングリコールモ [0031] Preferably, the (C) monomer is (meth) acrylamide, N-butyl-2-pyrrolidone, methoxypolyethylene glycol mono (meth) atalylate, and more preferably N-butyl 2 —Methoxypolyethylene glycol with an average number of repetitions of 2 to 25 for pyrrolidone and (CHO)
2 4  twenty four
ノ (メタ)アタリレートである。(C)単量体は、上記化合物に限定されるものではなぐ 1 種単独で又は 2種以上を適宜組み合わせて用いることができる。  No (meta) atarilate. The monomer (C) is not limited to the above compounds, and may be used alone or in combination of two or more.
[0032] (C)単量体の含有量は、全単量体中に 0. 1— 78. 9質量%、好ましくは 15— 73質 量%で、より好ましくは 30— 65質量%である。(C)単量体の含有量が少なすぎると水 溶性が減り、多すぎると対象とする表面への吸着性が劣る。  [0032] The content of the monomer (C) is 0.1 to 78.9% by mass, preferably 15 to 73% by mass, more preferably 30 to 65% by mass, based on all the monomers. . (C) If the content of the monomer is too small, the water solubility is reduced, and if the content is too large, the adsorptivity to the target surface is poor.
[0033] 本発明の高分子化合物は、重量平均分子量が 5, 000— 1, 000, 000であり、好 まし <は 10, 000— 500, 000、より好まし <は 10, 000— 400, 000である。重量平 均分子量が小さすぎると、例えばゲル表面に使用したときに、そのポアサイズより小さ くなり、大きすぎると高分子化合物溶液の粘度が高くなりすぎて製剤設計上の制限が 生じる。なお、重量平均分子量は、本発明においてはゲルパーミエーシヨンクロマトグ ラフィ一で、 0. 5molZL酢酸、 0. 5molZL酢酸ナトリウムの水 Zエタノール = 50Z 50 (νΖν%)溶液を移動相とし、ポリエチレングリコールを標準として求めることができ る。  [0033] The polymer compound of the present invention has a weight average molecular weight of 5,000-1,000,000, preferably <10,000-500,000, and more preferably <10,000-400, 000. If the weight average molecular weight is too small, for example, when used on a gel surface, it will be smaller than its pore size, and if it is too large, the viscosity of the polymer compound solution will be too high, thus limiting the design of the formulation. In the present invention, the weight average molecular weight is gel permeation chromatography, 0.5 mol ZL acetic acid, 0.5 mol ZL sodium acetate in water Z ethanol = 50 Z 50 (νΖν%) solution is used as a mobile phase, and polyethylene glycol is used. It can be obtained as a standard.
[0034] 本発明の高分子化合物の製造方法は、上記 (Α)— (C)単量体を共重合した共重 合体を作製できれば特に限定されないが、例えば溶液重合、懸濁重合、塊状重合に より重合することができる。工業的には、溶液重合、懸濁重合によるラジカル重合が 好ましぐ中でも溶液重合による方法が好ましい。なお、本発明の共重合体は、ラン ダム共重合体であってもブロック共重合体であってもよい。  [0034] The method for producing the polymer compound of the present invention is not particularly limited as long as a copolymer obtained by copolymerizing the above (上 記)-(C) monomers can be produced. Examples thereof include solution polymerization, suspension polymerization, and bulk polymerization. Can be polymerized. Industrially, a method based on solution polymerization is preferred, even though radical polymerization based on solution polymerization or suspension polymerization is preferred. In addition, the copolymer of the present invention may be a random copolymer or a block copolymer.
[0035] 溶液重合によって重合する場合、溶媒としては、例えば水、メチルアルコール、ェ チルアルコール、イソプロピルアルコール等の低級アルコール、ベンゼン、トルエン、 キシレン、シクロへキサン、へキサン等の芳香族、脂肪族又は複素環式化合物、酢酸 ェチル、アセトン、メチルェチルケトン等の各種有機溶剤が使用できる。重合濃度は 特に制限されないが、通常 10— 50質量%で重合するのがよい。  [0035] In the case of performing polymerization by solution polymerization, examples of the solvent include water, lower alcohols such as methyl alcohol, ethyl alcohol, and isopropyl alcohol; aromatics such as benzene, toluene, xylene, cyclohexane, and hexane; Alternatively, various organic solvents such as heterocyclic compounds, ethyl acetate, acetone, and methyl ethyl ketone can be used. Although the polymerization concentration is not particularly limited, it is usually preferable to carry out the polymerization at 10 to 50% by mass.
[0036] 重合開始剤としては、例えば過硫酸アンモ-ゥム、過硫酸ナトリウム、過硫酸力リウ ム等の過硫酸塩、ベンゾィルパーオキサイド、ラウロイルパーオキサイド等のパーォキ サイド、クメンハイド口パーオキサイド、ハイド口パーオキサイド等のハイド口パーォキ サイド、ァゾビスイソプチ口-トリル等のァゾィ匕合物等が挙げられる。重合開始剤濃度 は、通常、使用する単量体合計量に対して 0. 1— 10モル%が好ましい。さらに、分 子量を規制するためにアルキルメルカブタンのような連鎖移動剤、ルイス酸化合物等 の重合促進剤、リン酸、クェン酸、酒石酸、乳酸等の pH調整剤を使用してもよい。重 合温度は、用いられる溶媒、重合開始剤により適宜定められるが、通常、室温一 150 °Cがよい。 [0036] Examples of the polymerization initiator include persulfates such as ammonium persulfate, sodium persulfate, and persulfuric acid potassium, peroxides such as benzoyl peroxide and lauroyl peroxide, cumenehydroxide, and the like. Examples thereof include a peroxide at the mouth such as a peroxide at the mouth, and an azoi conjugate such as azobis isopti-tolyl. Polymerization initiator concentration Is usually preferably 0.1 to 10 mol% based on the total amount of the monomers used. Further, in order to regulate the molecular weight, a chain transfer agent such as an alkyl mercaptan, a polymerization accelerator such as a Lewis acid compound, and a pH adjuster such as phosphoric acid, citric acid, tartaric acid, and lactic acid may be used. The polymerization temperature is appropriately determined depending on the solvent and the polymerization initiator to be used, but usually, the room temperature is preferably 150 ° C.
[0037] 得られた高分子化合物中に含まれる残存単量体等の低分子量不純物は、活性炭 、限界濾過、透析膜等を使用して処理することにより除去精製することができる。活性 炭としては、一般的に用いられる木材、石炭、椰子殻等を薬品や蒸気で賦活した物 等が挙げられ、その形状に関しても、粉体、破砕状、繊維状のもの等があるが特に限 定されない。限外濾過膜の材質としては、ポリスルホン、ポリエーテルスルホン、ポリビ ユリデンジフルオリド、酢酸セルロース、ニトロセルロース等が使用できる。その形状 に関しても平膜状、中空糸状等が挙げられるが、特に限定されない。  [0037] Low molecular weight impurities such as residual monomers contained in the obtained polymer compound can be removed and purified by treatment using activated carbon, ultrafiltration, a dialysis membrane or the like. Examples of activated carbon include commonly used wood, coal, coconut shells and the like activated with chemicals and steam, and the shape of the activated carbon is also powder, crushed, fibrous, etc. Not limited. As the material of the ultrafiltration membrane, polysulfone, polyethersulfone, polyvinylidene difluoride, cellulose acetate, nitrocellulose and the like can be used. The shape may be a flat membrane shape, a hollow fiber shape or the like, but is not particularly limited.
[0038] 本発明のタンパク付着防止用高分子化合物は、医療用具等の材料として使用され 、タンパク質に代表されるような生体由来物質が付着することによって材料の生体適 合性が悪ィ匕することが懸念されるガラス、セラミック、ステンレス、プラスチック等の硬 表面、毛髪、繊維等の軟表面、ゲル表面及びコンタクトレンズ表面に対して、低濃度 かつ単時間処理によっても優れたタンパク質付着防止能を有する。この高分子化合 物は、これらの表面に吸着して防汚性を付与し、水での濯ぎによっても簡単に流され ないことから、防汚性組成物に用いることができる。また、対象物を洗浄するとともに 防汚性を付与することができ、水での濯ぎを伴うような洗浄工程にぉ 、ても高分子化 合物が濯ぎによって流されず、対象面に吸着して防汚性を発現することから、洗浄性 防汚剤組成物に用いることができる。  [0038] The polymer compound for preventing protein adhesion of the present invention is used as a material for medical devices and the like, and the biocompatibility of the material is degraded by the attachment of a biological substance represented by a protein. It has excellent anti-protein-adhesion ability even at low concentration for a single hour on hard surfaces such as glass, ceramics, stainless steel, and plastic, soft surfaces such as hair and fibers, gel surfaces, and contact lens surfaces. Have. The polymer compound is adsorbed on these surfaces to impart antifouling properties, and is not easily washed away by rinsing with water, so that it can be used as an antifouling composition. In addition, the object can be washed and imparted with antifouling properties. Even in a washing step involving rinsing with water, the polymer compound is not washed away by the rinsing, but is adsorbed on the object surface. Since the antifouling agent exhibits antifouling properties, it can be used for a cleaning antifouling agent composition.
[0039] また、本発明のタンパク質付着防止用高分子化合物を含有してなる組成物は、上 記特性を有することから眼科用組成物として好適であり、コンタクトレンズ用として特 に好適である。眼科用組成物としては、一般点眼薬、抗菌性点眼薬、人工涙液、コン タクトレンズ装着液、洗眼薬等が挙げられる。コンタクトレンズ用組成物としては、具体 的には、コンタクトレンズ用処理液、洗浄液、保存液、洗浄保存液、洗浄消毒液等が 挙げられる。 [0040] 上記各組成物における本発明の高分子化合物の含有量は、特に制限されるもの ではないが、通常、各組成物全体に対して 0. 0001— 20質量%、好ましくは 0. 001 一 10質量%、より好ましくは 0. 005— 5質量%である。高分子化合物の含有量が少 なすぎると、その機能を充分に発揮できない場合があり、多すぎると製剤設計上の制 限が生じる場合がある。 Further, the composition containing the polymer compound for preventing protein adhesion of the present invention is suitable as an ophthalmic composition because of having the above-mentioned properties, and is particularly suitable as a contact lens. Examples of the ophthalmic composition include general eye drops, antibacterial eye drops, artificial tears, contact lens mounting solutions, eyewashes, and the like. Specific examples of the contact lens composition include a treatment solution for a contact lens, a cleaning solution, a preservative solution, a cleaning preservative solution, a cleaning disinfecting solution, and the like. [0040] The content of the polymer compound of the present invention in each of the above compositions is not particularly limited, but is usually 0.0001 to 20% by mass, preferably 0.001% by mass based on the whole of each composition. One 10% by mass, more preferably 0.005-5% by mass. If the content of the polymer compound is too small, its function may not be sufficiently exhibited, and if it is too large, there may be a limitation in formulation design.
[0041] 本発明の高分子化合物を各種組成物に含有させる場合、その用途に合わせて、ァ ユオン性、カチオン性、ノ-オン性及び両性の低分子量界面活性剤を 1種単独で又 は 2種以上を併用してもよい。このような低分子量界面活性剤としては、例えば、アル キルベンゼンスルホン酸塩、硫酸アルキルポリオキシエチレン塩、アルキルポリオキ シエチレンエーテル、脂肪酸ジエタノールアミド、 N アルキレンべタイン、ポリオキシ エチレン硬化ヒマシ油 60 (例えば、 HCO— 60、 日本サーファタタント工業 (株)製)等 のポリオキシエチレンォキシステアリン酸トリダリセライド、ポリソリベート 80 (例えば TO 10M、 日本サーファタタント工業 (株)製)等のモノォレイン酸ポリオキシエチレンソ ノレビタン、ポリオキシエチレンポリオキシプロピレンブロックポリマー、ポロキサミン(例 えば、 TETRONIC1107、 BASFジャパン (株)製)等が挙げられる。  When the polymer compound of the present invention is contained in various compositions, an aionic, cationic, nonionic or amphoteric low-molecular-weight surfactant may be used alone or in accordance with the intended use. Two or more kinds may be used in combination. Examples of such low molecular weight surfactants include alkylbenzene sulfonate, alkyl polyoxyethylene sulfate, alkyl polyoxyethylene ether, fatty acid diethanolamide, N alkylene betaine, polyoxyethylene hydrogenated castor oil 60 ( For example, polyoxyethylene oxocystearate tridalicelide such as HCO-60, manufactured by Nippon Surfatatanto Kogyo Co., Ltd., and polyoxymonooleate polyoxylates, such as polysoribate 80 (for example, TO 10M, manufactured by Nippon Surfatatanto Kogyo Co., Ltd.). Ethylene sonorevitan, polyoxyethylene polyoxypropylene block polymer, poloxamine (for example, TETRONIC1107, BASF Japan Ltd.) and the like.
[0042] 各種組成物には、上記成分の他に消毒剤、防腐剤、酵素、緩衝剤、安定剤、等張 ィ匕剤、溶解化剤、清涼化剤、粘稠化剤等を 1種単独で又は 2種以上併用してもよい。  [0042] In addition to the above-mentioned components, various compositions may include one kind of disinfectant, preservative, enzyme, buffer, stabilizer, isotonic sizing agent, solubilizer, freshener, thickener, and the like. They may be used alone or in combination of two or more.
[0043] 具体的には、消毒剤として、塩酸ポリへキサメチレンビグアニド、塩ィ匕ポリドロ-ゥム 等が挙げられる。防腐剤として、塩ィ匕ベンザルコ-ゥム、塩ィ匕セチルピリジ-ゥム、ソ ルビン酸、ソルビン酸カリウム、ノ ラオキシ安息香酸メチル、パラォキシ安息香酸ェチ ル、ノ ォキシ安息香酸プロピル、パラォキシ安息香酸ブチル等が挙げられる。酵素 として、トリプシン、キモトリブシン、パンダレアチン、パパイン、コラベナーゼ、プロメラ イン、アミノぺプチターゼ、ァスペルギロ.ぺプチターゼ、プロナーゼ E、デイスパーゼ 、ズブチリシン A、ズブチリシン B、リパーゼ、ダルコシダーゼ、ムタナーゼ、 α—ァミラ ーゼ、デキストラナーゼ等が挙げられる。緩衝剤として、ホウ酸、ホウ砂、トロメタモー ル、リン酸二水素ナトリウム、リン酸水素ニナトリウム、クェン酸、クェン酸ナトリウム、炭 酸水素ナトリウム、炭酸ナトリウム、 L-ァスパラギン酸カリウム、ィプシロン-アミノカプリ ン酸、グルタミン酸ナトリウム等が挙げられる。安定剤として、 α—シクロデキストリン、 ェデト酸ナトリウム、亜硫酸水素ナトリウム、チォ硫酸ナトリウム等が挙げられる。等張 ィ匕剤として、アミノエチルスルホン酸、塩ィ匕カリウム、塩ィ匕ナトリウム、塩ィ匕カルシウム、 グリセリン、ブドウ糖、 D マン-トール等が挙げられる。溶解化剤として、エタノール、 尿素、プロピレングリコール、マグロゴール 4000等のポリエチレングリコール、モノエ タノールァミン等が挙げられる。清涼化剤として、ウイキヨゥ油、 dl カンフル、ゲラ-ォ ール、ハツ力油、ベルガモット油、 d ボルネオール、 1 メントール、ユーカリ油等が挙 げられる。粘稠化剤として、コンドロイチン硫酸ナトリウム、ヒアルロン酸及びその塩、 デキストラン 70、ヒドロキシセルロース、ポリビニルアルコール、ポリビニルピロリドン等 が挙げられる。また、必要に応じて低級アルコール、抗菌剤、色素及び香料等を、そ れぞれ 1種単独で又は 2種以上を適宜組み合わせて用いることができる。 [0043] Specifically, examples of the disinfectant include polyhexamethylene biguanide hydrochloride, Shiridani polydrodium, and the like. As preservatives, Shiridani benzalco-pam, Shiridani cetyl pyrididium, sorbic acid, potassium sorbate, methyl noroxybenzoate, ethyl parahydroxybenzoate, propyl nonoxybenzoate, propyloxybenzoate Butyl and the like. Enzymes include trypsin, chymotrypsin, pandaleatin, papain, colavenase, promelain, aminopeptidase, aspergillus peptidase, pronase E, dispase, subtilisin A, subtilisin B, lipase, dalcosidase, mutanase, α-amylase, dextra And the like. Buffers include boric acid, borax, trometamol, sodium dihydrogen phosphate, disodium hydrogen phosphate, citric acid, sodium citrate, sodium hydrogen carbonate, sodium carbonate, potassium L-aspartate, epsilon-aminocapri Acid, sodium glutamate and the like. Α-cyclodextrin, Sodium edetate, sodium bisulfite, sodium thiosulfate and the like. Examples of the isotonic sizing agent include aminoethylsulfonic acid, potassium sulphite, sodium chloride, sulphite calcium, glycerin, glucose, D-mantol and the like. Examples of solubilizers include ethanol, urea, propylene glycol, polyethylene glycol such as Magrogol 4000, and monoethanolamine. Examples of fresheners include fennel oil, dl camphor, gerol, heart-strength oil, bergamot oil, d-borneol, 1 menthol, eucalyptus oil and the like. Examples of the thickener include sodium chondroitin sulfate, hyaluronic acid and salts thereof, dextran 70, hydroxycellulose, polyvinyl alcohol, polyvinyl pyrrolidone and the like. If necessary, a lower alcohol, an antibacterial agent, a dye, a fragrance and the like can be used alone or in an appropriate combination of two or more.
[0044] 特に、本発明の高分子化合物を含有する組成物を、医療用具等の材料として使用 されて、タンパク質に代表されるような生体由来物質が付着することによって材料の 生体適合性が悪ィ匕することが懸念されるガラスやセラミック、ステンレス、プラスチック 等の硬表面、毛髪、繊維等の軟表面、ゲル表面及びコンタクトレンズ表面に対し用い る場合、水溶性高分子化合物を配合することが好ましいことがある。特にコンタクトレ ンズ表面に用いる場合、本発明の高分子化合物と水溶性高分子化合物とを組み合 せることにより、例えばこすり洗いをする際の摩擦が減少し、対象物の破損をより良好 に防ぐことができる。 [0044] In particular, the composition containing the polymer compound of the present invention is used as a material for medical devices and the like, and the biocompatibility of the material is deteriorated due to the attachment of a biological substance represented by a protein. When used on hard surfaces such as glass, ceramics, stainless steel, and plastics, soft surfaces such as hair and fibers, gel surfaces, and contact lens surfaces that may cause danger, a water-soluble polymer compound may be added. May be preferred. In particular, when used on the surface of a contact lens, the combination of the polymer compound of the present invention and a water-soluble polymer compound reduces friction during scrubbing, for example, and better prevents damage to the object. be able to.
[0045] 水溶性高分子化合物としては、ヒドロキシセルロース、ヒドロキシプロピルメチルセル ロース、ヒドロキシェチルセルロース、メチルセルロース等のセルロース系高分子化合 物、ポリビュルアルコール、ポリビュルピロリドン、カルボキシビュルポリマー等のポリ ビュル系高分子化合物、コンドロイチン硫酸ナトリウム、ヒアルロン酸等のムコ多糖類 、ポリエチレングリコール、デキストラン等が挙げられる。この中でも好ましい水溶性高 分子化合物は、セルロース系高分子化合物、ポリビニル系高分子化合物、ポリェチ レンダリコール、ヒアルロン酸であり、特に好ましい化合物は、ヒドロキシプロピルメチ ノレセノレロース、ヒドロキシェチノレセノレロース、ポリビニノレアノレコーノレ、ポリビニノレピロリド ン、ポリエチレングリコール、ヒアルロン酸である。  [0045] Examples of the water-soluble polymer compound include cellulosic polymer compounds such as hydroxycellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, and methylcellulose; and polybutyl such as polybutyl alcohol, polybutylpyrrolidone, and carboxybutyl polymer. Examples include mucopolysaccharides such as a series polymer compound, sodium chondroitin sulfate, and hyaluronic acid, polyethylene glycol, and dextran. Among these, preferred water-soluble high-molecular compounds are cellulose-based polymer compounds, polyvinyl-based polymer compounds, polyethylene render glycols, and hyaluronic acid, and particularly preferred compounds are hydroxypropyl methinoresenolerose, hydroxyethenoresenorelose, and polyvinyl alcohol. Noreanolone, polyvinylinolepyrrolidone, polyethylene glycol and hyaluronic acid.
[0046] 上記水溶性高分子化合物の配合量は、特に制限されるものではな!/、が、通常、組 成物全体に対して 0. 0001— 20質量0 /0、好ましくは 0. 001— 10質量0 /0、より好まし くは 0. 005— 5質量%である。水溶性高分子化合物の配合量が少なすぎると、対象 面をこすり洗いする時の摩擦のため、対象物を破損する場合があり、多すぎると粘度 が高くなりすぎて製剤設計上の制限が生じる場合がある。 [0046] The amount of the water-soluble polymer compound to be added is not particularly limited! 0. for the entire Narubutsu 0001- 20 mass 0/0, preferably from 0.5 001 10 mass 0/0, more rather preferably is 0.5 005- 5 wt%. If the amount of the water-soluble polymer compound is too small, the object may be damaged due to friction when the target surface is scrubbed.If the amount is too large, the viscosity becomes too high and there is a restriction in the formulation design. There are cases.
[0047] 本発明の各組成物の剤型、調製方法、使用方法は特に限定されず、各組成物の 通常の剤型として各剤型の常法に準じて調製することができ、各剤型の常用量を通 常の使用方法にて使用することによって、優れた防汚性、洗浄防汚性を発揮すること ができる。 [0047] The dosage form, preparation method, and usage method of each composition of the present invention are not particularly limited, and each composition can be prepared as a normal dosage form according to a conventional method of each dosage form. By using the usual amount of the mold in the usual way of use, excellent antifouling property and cleaning antifouling property can be exhibited.
[0048] なお、本発明の高分子化合物を配合して上記各種組成物を調製する場合、水性 組成物として調製すると、表面処理後に水で濯いでも優れた防汚性を付与する防汚 剤組成物、さらに、水での洗浄工程において上記高分子化合物が濯ぎによって脱離 せず、有効成分として対象面に吸着して優れた防汚性を付与できる洗浄性防汚剤組 成物が得られる。  [0048] When the above-mentioned various compositions are prepared by blending the polymer compound of the present invention, when prepared as an aqueous composition, an antifouling agent imparting excellent antifouling properties even after rinsing with water after surface treatment. In the washing step with water, the above-mentioned polymer compound is not desorbed by rinsing, but is adsorbed on the target surface as an active ingredient to give a cleantable antifouling agent composition capable of imparting excellent antifouling properties. Can be
実施例  Example
[0049] 以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の 実施例に制限されるものではな 、。  Hereinafter, the present invention will be described in detail with reference to Examples and Comparative Examples, but the present invention is not limited to the following Examples.
[0050] [実施例 1]  [Example 1]
冷却還流管、滴下ロート、温度計、窒素導入管及び撹拌装置を取り付けたセパラブ ルフラスコにエタノール 200gを仕込み、撹拌しながら窒素ガスを導入して 78°Cに加 熱し、メタクリル酸ジメチルアミノエチル (以下、 DMと略す) 40. lg、メタクリル酸メチ ル(以下、 MMAと略す) 44. 7g、ビュルピロリドン(以下、 VPと略す) 65. 2g (全単量 体中の DM分 = 27質量%、全単量体中の MMA分 = 30質量%、全単量体中の VP 分 =43質量%)、及びエタノール 35gの混合溶液と、 2, 2— (ァゾビス(2—メチルブチ 口-トリル)) 0. 78g及びエタノール 115gの混合溶液とを連続的に 3時間かけてカロえ 、さらに 3時間加熱し続けて、表 1に示す組成の実施例 1の高分子化合物(共重合体 )を得た。  200 g of ethanol was charged into a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube and a stirrer, and nitrogen gas was introduced with stirring, heated to 78 ° C, and dimethylaminoethyl methacrylate (hereinafter referred to as dimethylaminoethyl methacrylate). , DM) 40. lg, methyl methacrylate (hereinafter abbreviated as MMA) 44.7 g, bulpyrrolidone (hereinafter abbreviated as VP) 65.2 g (DM content in total monomer = 27% by mass, MMA content in all monomers = 30% by mass, VP content in all monomers = 43% by mass), and a mixed solution of 35 g of ethanol and 2,2- (azobis (2-methylbutymouth-tolyl)) A mixed solution of 0.78 g and 115 g of ethanol was continuously calored over 3 hours, and further heated for 3 hours to obtain a polymer compound (copolymer) of Example 1 having the composition shown in Table 1. .
[0051] [実施例 2— 25]  [Example 2-25]
上記実施例 1において、表 1の組成となるように単量体の種類、配合割合を代えた 以外は、上記実施例 1と同様の方法によって表 1に示す組成の実施例 2— 25の高分 子化合物を得た。 In Example 1 above, the types and blending ratios of the monomers were changed so that the compositions shown in Table 1 were obtained. Except for the above, the polymer of Examples 2 to 25 having the composition shown in Table 1 was obtained in the same manner as in Example 1 above.
[0052] [実施例 26]  [Example 26]
冷却還流管、滴下ロート、温度計、窒素導入管及び撹拌装置を取り付けたセパラブ ルフラスコにエタノール 120gを仕込み、撹拌しながら窒素ガスを導入して内温を 78 。Cにカロ熱し、 DM11. 5g、 MMA25. 7g、 VP42. 4g、メ卜キシポリエチレングリ =f一 ルモノメタタリレート(ポリエチレン平均 = 9) (以下 M— 90Gと略す) 10. 3g (全単量体 中の DM分 = 12. 8質量%、全単量体中の MMA分 = 28. 6質量%、全単量体中の VP分 =47. 1質量%、全単量体中の M— 90G= 11. 5質量0 /0)及びエタノール 41g の混合溶液と、 2, 2- (ァゾビス(2-メチルブチ口-トリル)) 0. 71g及びエタノール 49 . lgの混合溶液とを連続的に 2時間かけて加え、さらに 4時間加熱し続けて重合反応 し共重合体を得た。共重合体の固形分が 2質量%になるようにイオン交換水を加える と同時に lmol%Lの塩酸水溶液をカ卩えて pHを 6に調整し、再生セルロース製透析 チューブ(UC36— 32— 100 ;Viskase Companies, Inc製)に入れ、イオン交換水 を取り替えながら 1週間透析を行なった。チューブ内の高分子化合物を含む水溶液 を凍結乾燥機を用いて乾燥し、表 3に示す組成の実施例 26の高分子化合物 (精製 共重合体)を得た。 120 g of ethanol was charged into a separable flask equipped with a cooling reflux tube, a dropping funnel, a thermometer, a nitrogen inlet tube and a stirrer, and nitrogen gas was introduced with stirring to adjust the internal temperature to 78. Heat calorie to C, DM11.5g, MMA25.7g, VP42.4g, methoxypolyethylene glycol = monomethyl methacrylate (polyethylene average = 9) (hereinafter abbreviated as M-90G) 10.3g (total single amount) DM content in body = 12.8% by weight, MMA content in all monomers = 28.6% by weight, VP content in all monomers = 47.1% by weight, M in all monomers 90G = 11. a mixed solution of 5 mass 0/0) and ethanol 41 g, 2, 2- (Azobisu (2 Mechirubuchi port - tolyl).) 0. 71 g and ethanol 49 continuously 2 and mixed solution of lg It was added over a period of time, and further heated for 4 hours to carry out a polymerization reaction to obtain a copolymer. At the same time, ion-exchanged water was added so that the solid content of the copolymer was 2% by mass, and at the same time, an aqueous solution of hydrochloric acid of 1 mol% L was added to adjust the pH to 6, and a regenerated cellulose dialysis tube (UC36-32-100; Viskase Companies, Inc.) and dialyzed for 1 week while replacing the ion-exchanged water. The aqueous solution containing the polymer compound in the tube was dried using a freeze dryer to obtain a polymer compound (purified copolymer) of Example 26 having the composition shown in Table 3.
[0053] [実施例 27— 62]  [Example 27-62]
上記実施例 26において、表 3の組成となるように単量体の種類、配合割合を代え た以外は、上記実施例 26と同様の方法によって表 3に示す組成の実施例 27— 62の 高分子化合物を得た。  In Example 26 above, except that the kind and the mixing ratio of the monomers were changed so as to obtain the composition shown in Table 3, the composition of Examples 27 to 62 having the composition shown in Table 3 was obtained in the same manner as in Example 26. A molecular compound was obtained.
[0054] [比較例 1, 2]  [Comparative Examples 1 and 2]
市販の下記高分子化合物を比較例 1, 2とした。  The following commercially available polymer compounds were used as Comparative Examples 1 and 2.
比較例 1:ポリビュルピロリドン(ポリビュルピロリドン K 90): BASF (株)製 比較例 2:ポリアクリル酸(カーボポール 934P): Noveon社製  Comparative Example 1: Polyvinylpyrrolidone (Polyvinylpyrrolidone K90): BASF Corporation Comparative Example 2: Polyacrylic acid (Carbopol 934P): Noveon
[0055] [比較例 3— 9]  [Comparative Examples 3-9]
上記実施例 1において、表 2の組成となるように単量体の種類、配合割合を代えた 以外は、上記実施例 1と同様の方法によって表 2に示す組成の比較例 3— 9の高分 子化合物を得た。 In Comparative Example 3-9 having the composition shown in Table 2, the same method as in Example 1 was used, except that the types and the proportions of the monomers were changed so as to obtain the composition shown in Table 2. Minute A child compound was obtained.
[0056] 上記実施例 1一 25及び比較例 1一 9の高分子化合物について、 0. 05質量%水溶 液での防汚性 1、防汚性 2及び防汚性 3の評価を下記方法に従って行った。また耐 久性の評価に関しては、上記実施例 1一 25の共重合体について、 0. 1質量%水溶 液で、及び比較例 1一 9について 1. 0質量%水溶液での評価を下記方法に従って 行った。さらに上記実施例 26— 62及び比較例 1一 9の高分子化合物について、 0. 0 5質量%水溶液で  For the polymer compounds of Example 125 and Comparative Example 119, the antifouling property 1, the antifouling property 2 and the antifouling property 3 in a 0.05% by mass aqueous solution were evaluated according to the following methods. went. Regarding the evaluation of durability, the copolymer of Example 125 above was evaluated with a 0.1% by mass aqueous solution, and that of Comparative Example 119 with a 1.0% by mass aqueous solution according to the following method. went. Further, with respect to the polymer compounds of Examples 26 to 62 and Comparative Example 19, a 0.05% by mass aqueous solution was used.
の防汚性 4、洗浄性の評価を下記方法に従って行った。結果を表 1一 4に併記する。  The antifouling property of 4, and detergency were evaluated according to the following methods. The results are shown in Table 1-4.
[0057] 〈防汚性 1の評価方法〉  <Evaluation method for antifouling property 1>
ステンレス板(10cm X 10cm)を濃度 0. 05質量%高分子化合物溶液又は分散液 500mLに室温で 1時間浸漬した。ステンレス板を取りだしてイオン交換水で濯ぎ、清 浄な柔らかい紙で水分を吸い取り、タンパク質の一種であるフイブリノ一ゲン 0. 60g をイオン交換水 500mLに溶解させた液にステンレス板を浸漬した後、 30°Cで 1時間 加温震盪した。ステンレス板を取りだし、清浄な柔らかい紙で水分を吸い取った。この ステンレス板は、ニンヒドリン指示薬を用いてステンレス版に付着したフイブリノ一ゲン を染色し、発色の状態を下記評価基準に従って評価した。  A stainless plate (10 cm × 10 cm) was immersed in 500 mL of a 0.05% by mass polymer solution or dispersion for 1 hour at room temperature. Remove the stainless steel plate, rinse with ion-exchanged water, absorb moisture with clean soft paper, immerse the stainless steel plate in a solution of 0.60 g of fibrinogen, a kind of protein, in 500 mL of ion-exchanged water, The mixture was heated and shaken at 30 ° C for 1 hour. The stainless steel plate was removed and water was absorbed with clean soft paper. The stainless plate was stained with fibrinogen attached to the stainless plate using a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
[0058] 〈評価基準〉  <Evaluation criteria>
5:全く染まらな 、 (ステンレス板をフイブリノ一ゲン溶液に接触させず、ニンヒドリン指 示薬を用 、た時の着色状態に相当)  5: Does not stain at all (corresponds to the colored state when using a ninhydrin indicator without contacting the stainless steel plate with the fibrinogen solution)
4 :ほとんど染まらない  4: hardly stained
3 :僅かに染まる  3: Slightly stained
2 :かなり染まる  2: Dyed considerably
1:激しく染まる (ステンレス板を高分子化合物溶液による処理をせず、フイブリノーゲ ン溶液に接触させて-ンヒドリン指示薬を用いた時の着色状態に相当)  1: Intense staining (corresponds to the colored state when a stainless steel plate is not treated with a polymer compound solution but is brought into contact with a fibrinogen solution and a -hydrin indicator is used)
[0059] 〈防汚性 2の評価方法〉 <Evaluation method of antifouling property 2>
EMAA (エチレン 'メタクリル酸重合体)榭脂(lOcmX IOcm) (三井'デュポン ポリ ケミカル (株)製)を濃度。. 05質量%高分子化合物溶液又は分散液 500mLに室温 で 1時間浸漬した。 EMAA榭脂を取りだしてイオン交換水で濯ぎ、清浄な柔らかい 紙で水分を吸 、取り、タンパク質の一種である卵白リゾチーム溶液 (和光純薬 (株)製EMAA (ethylene methacrylic acid polymer) resin (10 cmX IOcm) (Mitsui DuPont Polychemical Co., Ltd.) concentration. It was immersed in 500 mL of a 0.05% by mass polymer solution or dispersion at room temperature for 1 hour. Take out the EMAA fat and rinse with ion exchanged water, clean and soft Egg white lysozyme solution (a type of protein) made by absorbing and absorbing moisture with paper (manufactured by Wako Pure Chemical Industries, Ltd.)
) 0. 60gをイオン交換水 500mLに溶解させた液に EMAA榭脂を浸漬した後、 30°C で 1時間加温震盪した。 EMAA榭脂を取りだし、清浄な柔らかい紙で水分を吸い取 つた。この EMAA榭脂は、ニンヒドリン指示薬を用いて EMAA榭脂に付着したリゾチ ームを染色し、発色の状態を下記評価基準に従って評価した。 EMAA resin was immersed in a solution of 0.60 g in 500 mL of ion-exchanged water, and heated and shaken at 30 ° C for 1 hour. The EMAA 榭 fat was removed and water was absorbed with clean soft paper. This EMAA resin was stained for lysozyme attached to the EMAA resin using a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
[0060] 〈評価基準〉 [0060] <Evaluation criteria>
5:全く染まらな 、 (EMAA榭脂を卵白リゾチーム溶液に接触させず、ニンヒドリン指 示薬を用 、た時の着色状態に相当)  5: Not stained at all (equivalent to colored state when EMAA fat is not brought into contact with egg white lysozyme solution and ninhydrin indicator is used)
4 :ほとんど染まらない  4: hardly stained
3 :僅かに染まる  3: Slightly stained
2 :かなり染まる  2: Dyed considerably
1:激しく染まる (EMAA榭脂を高分子化合物溶液による処理をせず、卵白リゾチ一 ム溶液に接触させて-ンヒドリン指示薬を用いた時の着色状態に相当)  1: Intense staining (equivalent to the colored state when EMAA 榭 fat is not treated with a polymer compound solution but is brought into contact with an egg white lysozyme solution and a -hydrin indicator is used)
[0061] 〈防汚性 3の評価方法〉  <Evaluation method for antifouling property 3>
上記防汚性 2の評価方法にお!、て、 EMAA榭脂をソフトコンタクトレンズ [1DAY ACUVUE (ジョンソン アンド ジョンソン (株)製)]に代え、リゾチームの染色剤とし て 0. 05質量%エリス口シン水溶液を用いた以外は、上記防汚性 2の評価方法と同 様の方法によって、ソフトコンタクトレンズに付着した卵白リゾチームを染色し、発色の 状態を下記評価基準に従って評価した。  In the above method for evaluating antifouling property 2, EMAA resin was replaced with a soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co.)], and 0.05% by mass of Eris mouth was used as a lysozyme stain. The egg white lysozyme adhered to the soft contact lens was stained in the same manner as in the evaluation method of the antifouling property 2 except that the aqueous solution of syn was used, and the state of color development was evaluated according to the following evaluation criteria.
[0062] 〈評価基準〉  [0062] <Evaluation criteria>
5:全く染まらな ヽ(ソフトコンタクトレンズを卵白リゾチーム溶液に接触させず、エリス口 シン水溶液を用 V、た時の着色状態に相当)  5: Does not stain at all ヽ (Equivalent to the colored state when a soft contact lens is not in contact with the egg white lysozyme solution and an aqueous solution of erythrocyte is used V)
4 :ほとんど染まらない  4: hardly stained
3 :僅かに染まる  3: Slightly stained
2 :かなり染まる  2: Pretty dyed
1:激しく染まる(ソフトコンタクトレンズを高分子化合物溶液による処理をせず、卵白リ ゾチーム溶液に接触させてエリス口シン水溶液を用いた時の着色状態に相当) 1: Intense staining (corresponds to the colored state when using a solution of erythrocycin in contact with an egg white lysozyme solution without treating the soft contact lens with a polymer compound solution)
[0063] 〈耐久性の評価方法〉 ソフトコンタクトレンズ [1DAY ACUVUE (ジョンソン ·アンド'ジョンソン (株)製)]を 、上記実施例 1一 25及び比較例 1一 9の高分子化合物溶液 (実施例 1一 25の高分 子化合物 0. 1質量%水溶液、比較例 1一 9の高分子化合物 1. 0質量%水溶液) 50 OmUこ、室温で 1時間浸漬した。ソフトコンタクトレンズを取りだしてイオン交換水で濯 ぎ、清浄な柔らかい紙で水分を吸い取り、タンパク質の一種である卵白リゾチーム溶 液(和光純薬 (株)製) 0. 60gをイオン交換水 500mLに溶解させた液にソフトコンタク トレンズを浸漬した後、 30°Cでそれぞれ 15時間及び 30時間加温震盪した。ソフトコ ンタクトレンズを取りだし、清浄な柔らかい紙で水分を吸い取った。このソフトコンタクト レンズについて、ニンヒドリン指示薬を用いてレンズに付着したリゾチームを染色し、 発色の状態を下記評価基準に従って評価した。 <Durability Evaluation Method> The soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co., Ltd.)] was added to the polymer compound solution of Example 125 and Comparative Example 119 (the polymer compound of Example 125). 1% by mass aqueous solution, Comparative Example 11: High molecular weight compound of 1.0 1.0% by mass aqueous solution) 50 OmU, and immersed at room temperature for 1 hour. Remove the soft contact lens, rinse with ion-exchanged water, absorb the moisture with clean soft paper, and dissolve 0.60 g of egg white lysozyme solution (a product of Wako Pure Chemical Industries, Ltd.) in 500 mL of ion-exchanged water. After immersing the soft contact lens in the solution, the mixture was heated and shaken at 30 ° C for 15 hours and 30 hours, respectively. I took out the soft contact lens and absorbed the moisture with clean soft paper. For this soft contact lens, lysozyme attached to the lens was stained with a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
[0064] 〈評価基準〉 [0064] <Evaluation criteria>
5:全く染まらな 、(ソフトコンタクトレンズを卵白リゾチーム溶液に接触させず、ニンヒド リン指示薬を用 、た時の着色状態に相当)  5: No staining at all (corresponds to the colored state when using a ninhydrin indicator without contacting the soft contact lens with the egg white lysozyme solution)
4 :ほとんど染まらない  4: hardly stained
3 :僅かに染まる  3: Slightly stained
2 :かなり染まる  2: Pretty dyed
1:激しく染まる(ソフトコンタクトレンズを高分子化合物溶液による処理をせず、卵白リ ゾチーム溶液に接触させて-ンヒドリン指示薬を用いた時の着色状態に相当)  1: Intense staining (corresponds to the colored state when a soft contact lens is not treated with a polymer compound solution but is in contact with an egg white lysozyme solution and a -hydrin indicator is used)
[0065] 〈防汚性 4の評価方法〉 <Evaluation method for antifouling property 4>
ソフトコンタクトレンズ [1DAY ACUVUE (ジョンソン ·アンド'ジョンソン (株)製)]を 上記実施例 26— 62及び比較例 1一 9の高分子化合物溶液 (高分子化合物濃度 0. 05質量%、塩ィ匕ナトリウム 0. 9質量%) 4mLに、室温で 4時間浸漬した。ソフトコンタ クトレンズを取りだしてイオン交換水で濯ぎ、清浄な柔らか 、紙で水分を吸 ヽ取った。 このソフトコンタクトレンズを、卵白リゾチーム (和光純薬 (株)製) 0. 12質量0 /0、牛血 清アルブミン 0. 388質量0 /0 (fraction V,ナカライテスタ (株)製)、 γ—グロブリン 0. 161質量0 /0 (bovine, cohn F— 2,ナカライテスタ (株)製)、塩ィ匕ナトリウム 0. 9質量 %及びリン酸水素ニナトリウム 0. 045質量0 /0を混合した卵白リゾチーム溶液 2mLに 浸漬し、 37°Cで 1時間加温震盪した。ソフトコンタクトレンズを取りだし、清浄な柔らか い紙で水分を吸い取った。このソフトコンタクトレンズについて、ニンヒドリン指示薬を 用いてレンズに付着したタンパク質を染色し、発色の状態を下記評価基準に従って 評価した。 The soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson Co., Ltd.)] was used as the polymer compound solution of the above Examples 26-62 and Comparative Example 119 (polymer compound concentration: 0.05% by mass, (0.9% by mass of sodium) in 4 mL at room temperature for 4 hours. The soft contact lens was taken out, rinsed with ion-exchanged water, and wiped clean and soft with paper. The soft contact lenses, egg white (manufactured by Wako Pure Chemical Co.) Lysozyme 0.12 mass 0/0, bovine blood Kiyoshi albumin 0.388 mass 0/0 (fraction V, Nacalai Tester Co.), .gamma. globulin 0.161 mass 0/0 (bovine, Cohn F- 2, Nacalai tester Co.), egg white were mixed Shioi匕sodium 0.9 wt% and disodium hydrogen phosphate 0.045 mass 0/0 It was immersed in 2 mL of lysozyme solution and heated and shaken at 37 ° C for 1 hour. Take out the soft contact lens, clean and soft Moistened paper with a wet paper. With respect to this soft contact lens, a protein attached to the lens was stained with a ninhydrin indicator, and the state of color development was evaluated according to the following evaluation criteria.
[0066] 〈評価基準〉  [0066] <Evaluation criteria>
5:全く染まらな 、(ソフトコンタクトレンズを卵白リゾチーム溶液に接触させず、ニンヒド リン指示薬を用 、た時の着色状態に相当)  5: No staining at all (corresponds to the colored state when using a ninhydrin indicator without contacting the soft contact lens with the egg white lysozyme solution)
4 :ほとんど染まらない  4: hardly stained
3 :僅かに染まる  3: Slightly stained
2 :かなり染まる  2: Pretty dyed
1:激しく染まる(ソフトコンタクトレンズを高分子化合物溶液による処理をせず、卵白リ ゾチーム溶液に接触させて-ンヒドリン指示薬を用いた時の着色状態に相当)  1: Intense staining (corresponds to the colored state when a soft contact lens is not treated with a polymer compound solution but is in contact with an egg white lysozyme solution and a -hydrin indicator is used)
[0067] 〈洗浄性の評価方法〉  <Evaluation Method for Detergency>
ソフトコンタクトレンズ [1DAY ACUVUE (ジョンソン ·アンド'ジョンソン (株)製)]を イオン交換水で濯ぎ、清浄な柔らかい紙で水分を吸い取った。このソフトコンタクトレ ンズを、卵白リゾチーム (和光純薬 (株)製) 0. 12質量%、牛血清アルブミン 0. 388 質量0 /"fraction V,ナカライテスタ(株)製)、 γ—グロブリン 0. 161質量0 /0 (bovine , cohn F— 2,ナカライテスタ (株)製)、塩ィ匕ナトリウム 0. 9質量%及びリン酸水素二 ナトリウム 0. 045質量%を混合した卵白リゾチーム溶液 2mLに浸漬した後、 37°Cで 1時間加温震盪した。ソフトコンタクトレンズを取りだし、清浄な柔らかい紙で水分を吸 い取った後、上記実施例 26— 62及び比較例 1一 9の高分子化合物溶液 (高分子化 合物濃度 0. 05質量%、塩ィ匕ナトリウム 0. 9質量0 /0)を、コンタクトレンズ片面につき 3 mLづっ滴下して擦り洗いをした。このソフトコンタクトレンズについて、ニンヒドリン指 示薬を用いてレンズに付着しているタンパク質を染色し、発色の状態を下記評価基 準に従って評価した。 A soft contact lens [1DAY ACUVUE (manufactured by Johnson & Johnson)] was rinsed with ion-exchanged water, and moisture was absorbed with clean soft paper. 0.12% by mass of egg white lysozyme (manufactured by Wako Pure Chemical Industries, Ltd.), 0.388% by mass of bovine serum albumin 0 / "fraction V, manufactured by Nakarai Testa Co., Ltd." 161 mass 0/0 (bovine, cohn F- 2, Nacalai tester Co.), dipped in egg white lysozyme solution 2mL were mixed Shioi匕sodium 0.9 wt% and disodium hydrogen 0.045 wt% phosphoric acid After heating and shaking for 1 hour at 37 ° C, the soft contact lens was taken out, the moisture was absorbed with clean soft paper, and then the polymer solution of Examples 26-62 and Comparative Example 19-19 was obtained. (polymerized compound concentration 0.05 wt%, Shioi匕sodium 0.9 mass 0/0) were the scrubbed with 3 mL Dzu' dropwise per contact lens one side. this soft contact lenses, ninhydrin finger Protein attached to the lens using an indicator Stained, and evaluate the state of the color in accordance with the following evaluation criteria.
[0068] 〈評価基準〉  <Evaluation criteria>
5 :全く染まらない (使用済みソフトコンタクトレンズに付着したタンパク質汚れがほぼ 洗浄された状態に相当)  5: No staining (equivalent to almost all protein stains on used soft contact lenses have been washed)
4 :ほとんど染まらない 3:僅かに染まる 4: hardly stained 3: Slightly stain
2:かなり染まる 2: fairly stained
1:激しく染まる (使用済みコンタクトレンズに付着したタンパク質汚れがほとんど取れ ていないことに相当) 1: Intense staining (corresponds to almost no removal of protein stains from used contact lenses)
Figure imgf000022_0001
2]
Figure imgf000022_0001
2]
防汚性 防汚性 防汚性  Antifouling properties Antifouling properties Antifouling properties
耐久性 高分子化合物組成 重量平均 1 2 3 Durability Polymer compound composition Weight average 1 2 3
(質畺%) 分子量 E AA ソ: 7 コンタクト 30 15 ステンレス (Quality%) Molecular weight E AA S: 7 Contact 30 15 Stainless steel
樹脂 時間 時間 ポリビニルピロリドン  Resin Time Time Polyvinylpyrrolidone
1 一 1 1 1 1 1 (K-90)  1 1 1 1 1 1 1 (K-90)
2 ポリアクリノレ酸 1 1 1 1 1 2 Polyacrinoleic acid 1 1 1 1 1
3 DM/AA/MMA-25/70/5 95,000 2 1 1 1 13 DM / AA / MMA-25 / 70/5 95,000 2 1 1 1 1
4 D / AA/HE A=0. 1/35/64.9 70,000 2 1 1 1 1 比 4 D / AA / HE A = 0.1 / 35 / 64.9 70,000 2 1 1 1 1 Ratio
較 5 MAA/AA=40/60 78,000 1 1 1 1 1 例 Comparison 5 MAA / AA = 40/60 78,000 1 1 1 1 1 Example
6 M- 230G/AA-20/80 89,000 2 1 1 1 1 6 M- 230G / AA-20 / 80 89,000 2 1 1 1 1
7 DMC/EMA/VP=0.8/22/77.2 2,000 2 1 2 1 17 DMC / EMA / VP = 0.8 / 22 / 77.2 2,000 2 1 2 1 1
8 DMC/iVlAA/ MA/VP-0.1/20/2/77.9 34,000 1 1 1 1 18 DMC / iVlAA / MA / VP-0.1 / 20/2 / 77.9 34,000 1 1 1 1 1
9 DMC/MAA/M— 230G=15/82/3 22,000 1 1 1 1 1 9 DMC / MAA / M— 230G = 15/82/3 22,000 1 1 1 1 1
Figure imgf000024_0001
Figure imgf000024_0001
^¾0071 [0072] [表 4] ^ ¾0071 [Table 4]
Figure imgf000025_0001
Figure imgf000025_0001
[0073] [実施例 63— 66,比較例 10, 11」 [Examples 63-66, Comparative Examples 10, 11]
表 5の組成に準じて、常法に基づき防汚剤組成物、防汚洗浄剤組成物を調製した 。得られた防汚剤組成物、防汚洗浄剤組成物を前述の防汚性 3の評価方法におい て、 0. 05質量%の高分子化合物溶液又は分散液を、防汚剤組成物、防汚洗浄剤 組成物に変えた以外は同様の方法で評価した。結果を表 5に併記する。  An antifouling agent composition and an antifouling cleaning composition were prepared according to a conventional method according to the compositions shown in Table 5. The obtained antifouling agent composition and antifouling detergent composition were subjected to the above-mentioned method for evaluating antifouling property 3 by adding 0.05% by mass of a polymer compound solution or dispersion to the antifouling agent composition and the antifouling composition. Evaluation was made in the same manner except that the composition was changed to a soil cleaning composition. The results are shown in Table 5.
[0074] [表 5] [Table 5]
実施例 比較例 組成 (質量%) Example Comparative Example Composition (% by mass)
63 64 65 66 10 11 実施例 1 0.03 ― - 実施例 2 0.03 - 高分子 - 実施例 3 - 0.03 - 化合物 実施例 55 - 0.03  63 64 65 66 10 11 Example 1 0.03--Example 2 0.03-Polymer-Example 3-0.03-Compound Example 55-0.03
比較例 1 ― L0 比較例 2 ― ― 1.0 塩酸ポリへキサメチレンビグアニド 0.0001 0.00007 0.0001 0.0001 ― 塩化ポリド ニゥム 0.011 ― 0.011 Comparative Example 1 ― L0 Comparative Example 2 ― ― 1.0 Polyhexamethylene biguanide hydrochloride 0.0001 0.00007 0.0001 0.0001 ― Polydmium chloride 0.011 ― 0.011
10%塩化ベンザルコニゥム液 - 0- 1 ― 10% benzalkonium chloride solution-0-1-
α -シク σデキストリン ― 0.1 - ズブチリシン A 0.005 0.005 0.005 0.005 0.005 0.005 ポリオキシエチレン硬化ヒマシ油 60 0.1 0-1 ― 0-1 ポリソ ト 80 0.05 ― ― 0.05 α-sig σ dextrin ― 0.1-Subtilisin A 0.005 0.005 0.005 0.005 0.005 0.005 Polyoxyethylene hydrogenated castor oil 60 0.1 0-1 ― 0-1 Polysolute 80 0.05 ― ― 0.05
TETRONIC1107 0.3 0.3 0-3 0.3 0.3 0.3 ニューポール PE68 0.5 0.5 0.5 0.5 0.5 0.5 ホウ酸 0.3 ― 一 0.3 0.3 ホウ砂 0,05 0.05 0.05 トロメタモー 0.3 ― 0.3 リン酸二水素ナトリウム(2水和物) ― 0.08 ― リン酸水素ニナトリウム(12水和物) 0.5 ― クェン酸 0.05 0.05 0.05 0.05 0.05 0.05 ェデト酸ナトリウム 0.01 0.01 0.01 0.01 0.01 0.01 塩化ナトリウム 0.1 - ― 0.1 0.1 グリセリン 0.1 0.1 0.1 マンニ 1、一ル 0.1 ― TETRONIC1107 0.3 0.3 0-3 0.3 0.3 0.3 Newpol PE68 0.5 0.5 0.5 0.5 0.5 0.5 Boric acid 0.3 ― One 0.3 0.3 Borax 0,05 0.05 0.05 Tromethamore 0.3 ― 0.3 Sodium dihydrogen phosphate (dihydrate) ― 0.08 ― Disodium hydrogen phosphate (decahydrate) 0.5-Cuenoic acid 0.05 0.05 0.05 0.05 0.05 0.05 Sodium edetate 0.01 0.01 0.01 0.01 0.01 0.01 Sodium chloride 0.1--0.1 0.1 Glycerin 0.1 0.1 0.1 Manni 1, 1 0.1-
プロピレングリコール 0.2 0.2 0.2 0.2 0.2 0-2 Propylene glycol 0.2 0.2 0.2 0.2 0.2 0-2
1 -メントール, 0.002 0.002 0.002 0.002 0.002 0.0021-menthol, 0.002 0.002 0.002 0.002 0.002 0.002
L-ァスパラギン酸カリウム 0.25 0.25 0.25 0.25 0.25 0.25 アミノエチルスルホン酸 1.0 1.0 1.0 1.0 1.0 1.0Potassium L-aspartate 0.25 0.25 0.25 0.25 0.25 0.25 aminoethylsulfonic acid 1.0 1.0 1.0 1.0 1.0 1.0
L-グルタミン酸ナトリウム 0.1 0.1 0.1 0.1 0Λ 0.1 希塩酸 適量 Sodium L-glutamate 0.1 0.1 0.1 0.1 0Λ 0.1 Dilute hydrochloric acid qs
水酸化ナトリウム 適量  Sodium hydroxide appropriate amount
精製水 ランス  Purified water lance
100 100
Η 7  Η 7
防污性 3 5 5 5 5 1 1  3 5 5 5 5 1 1
30時間 5 5 5 5 1 1 耐久性  30 hours 5 5 5 5 1 1 Durability
15時間 5 5 5 5 1 1  15 hours 5 5 5 5 1 1
表中の略号を下記に示す。 The abbreviations in the table are shown below.
• DM:メタクリル酸ジメチルアミノエチル  • DM: Dimethylaminoethyl methacrylate
• DMA:アクリル酸ジメチルアミノエチル • DMAPAA:ジメチルァミノプロピルアタリノレアミド • DMA: dimethylaminoethyl acrylate • DMAPAA: Dimethylaminopropyl atalinoleamide
• DMAPMA:ジメチルァミノプロピルメタクリルアミド  • DMAPMA: dimethylaminopropyl methacrylamide
• DMC:メタタリ酸ジメチルアミノエチルメチルクロライド  • DMC: dimethylaminoethyl methyl methacrylate chloride
• MMA:メタクリノレ酸メチル  • MMA: Methyl methacrylate
• EMA:メタクリル酸ェチル  • EMA: Ethyl methacrylate
• BMA:メタクリル酸 n ブチル  • BMA: n-butyl methacrylate
• t-BMA:メタクリル酸 t ブチル  • t-BMA: t-butyl methacrylate
•VP :ビニノレピロリドン • VP: Vininolepyrrolidone
•M—90G :メトキシポリエチレングリコールモノメタタリレート(メタクリル酸メトキシポリエ チレングリコール)(ポリヱチレン平均 = 9) (新中村化学工業 (株)製)  • M-90G: Methoxypolyethylene glycol monomethacrylate (methoxypolyethylene glycol methacrylate) (polyethylene average = 9) (Shin-Nakamura Chemical Co., Ltd.)
•M—230G :メトキシポリエチレングリコールモノメタタリレート(メタクリル酸メトキシポリ エチレングリコール)(ポリヱチレン平均 = 23) (新中村ィ匕学工業 (株)製)• M-230G: Methoxy polyethylene glycol monomethacrylate (methoxypolyethylene glycol methacrylate) (polyethylene average = 23)
• HEMA:メタクリノレ酸ヒドロキシェチル • HEMA: hydroxyethyl methacrylate
•AA:アクリル酸 • AA: acrylic acid
•MAA:メタクリノレ酸  MAA: Methacryloleic acid
•TETORONIC 1107:ポロキサミン(BASFジャパン (株)製)  • TETORONIC 1107: Poloxamine (manufactured by BASF Japan Ltd.)
•ニューポール PE68:プル口ニック型非イオン界面活性剤(三洋化成 (株)製) • New Pole PE68: Pull mouth nick type nonionic surfactant (manufactured by Sanyo Chemical Co., Ltd.)
請求の範囲 The scope of the claims
[1] 下記 (A)、(B)及び (C)を共重合してなり、重量平均分子量が 5, 000— 1, 000, 0 00であるタンパク質付着防止用高分子化合物。  [1] A polymer compound for preventing protein adhesion, which is obtained by copolymerizing the following (A), (B) and (C) and has a weight average molecular weight of 5,000 to 1,000,000, 000.
(A) (A— 1)下記一般式(1)で表される 3級アミノ基を有する単量体 0. 1— 75質量% 及び Z又は (A - 2)下記一般式(2)で表される 4級アンモニゥム基を有する単量体 0 . 1一 7質量%  (A) (A-1) 0.1 to 75% by mass of a monomer having a tertiary amino group represented by the following general formula (1) and Z or (A-2) represented by the following general formula (2) 0.1 to 7% by mass of a monomer having a quaternary ammonium group
[化 1]  [Chemical 1]
Figure imgf000028_0001
Figure imgf000028_0001
(式中、 R1は水素原子又はメチル基、 Aは酸素原子又は NH、 R R3は独立に、水素 原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基、 R4、 R5は独立に、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示し、 mは 0、 1又は 2である。 ) (Wherein, R 1 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, RR 3 is independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms, and R 4 and R 5 are Independently, it represents a linear or branched alkyl group having 1 to 4 carbon atoms, and m is 0, 1 or 2.)
[化 2]  [Formula 2]
Figure imgf000028_0002
Figure imgf000028_0002
(式中、 R6は水素原子又はメチル基、 Aは酸素原子又は NH、 R7、 R8は独立に、水素 原子又は炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基、 R9、 R1Q及び R11は独立に 、炭素数 1一 4の直鎖もしくは分岐鎖のアルキル基を示し、 nは 0、 1又は 2、 Xは、ハロ ゲン、 OH、 1/2SO、 HSO、 1/3PO、 HCO又は CH COを示す。) (Wherein, R 6 is a hydrogen atom or a methyl group, A is an oxygen atom or NH, R 7 and R 8 are each independently a hydrogen atom or a linear or branched alkyl group having 14 to 14 carbon atoms, R 9 , R 1Q and R 11 each independently represent a linear or branched alkyl group having 14 to 14 carbon atoms, n is 0, 1 or 2, and X is halogen, OH, 1 / 2SO, HSO, 1 / 3 Indicates PO, HCO or CH CO.)
4 4 4 2 3 2  4 4 4 2 3 2
(B)下記一般式(3)で表される (メタ)アクリル酸エステル単量体 21— 80質量% CH =C (R12) COOR13 (3) (B) (meth) acrylic acid ester monomer represented by the following general formula (3) 21-80% by mass CH = C (R 12 ) COOR 13 (3)
2  2
(式中、 R12は水素原子又はメチル基であり、 R13は炭素数 1一 6の直鎖もしくは分岐鎖 のアルキル基である。) (Wherein, R 12 is a hydrogen atom or a methyl group, and R 13 is a linear or branched chain having 16 carbon atoms. Is an alkyl group. )
(C) (A) , (B)単量体以外のノニオン性水溶性単量体 0. 1— 78. 9質量%  (C) Nonionic water-soluble monomers other than (A) and (B) monomers 0.1—78.9 mass%
[2] 請求項 1記載の高分子化合物を含有してなることを特徴とする防汚剤組成物。 [2] An antifouling composition comprising the polymer compound according to claim 1.
[3] 請求項 1記載の高分子化合物を含有してなることを特徴とする洗浄性防汚剤組成 物。 [3] A cleaning antifouling composition comprising the polymer compound according to claim 1.
[4] 請求項 1記載の高分子化合物を含有してなることを特徴とする眼科用組成物。  [4] An ophthalmic composition comprising the polymer compound according to claim 1.
[5] 請求項 1記載の高分子化合物を含有してなることを特徴とするコンタクトレンズ用組 成物。 [5] A composition for a contact lens, comprising the polymer compound according to claim 1.

Claims

要 約 書 【要約】 【解決手段】 (A) ( 1)で表される単量体及び Z又は(2)で表される単量体 [Summary] (A) Monomer represented by (1) and monomer represented by Z or (2)
【化 1】 [Formula 1]
Figure imgf000030_0001
Figure imgf000030_0001
(R1は水素又はメチル基、 Aは酸素又は NH、
Figure imgf000030_0002
R3は水素又はアルキル基、 R4及び R5はアル キル基)
(R 1 is hydrogen or methyl group, A is oxygen or NH,
Figure imgf000030_0002
R 3 is hydrogen or an alkyl group, R 4 and R 5 are alkyl groups)
【化 2】
Figure imgf000030_0003
[Formula 2]
Figure imgf000030_0003
(R6は水素又はメチル基、 Aは酸素又は NH、 R R8は水素又はアルキル基、 R9、 Rw及び R11 はアルキル基、 nは 0、 1又は 2、 Xはハロゲン) (R 6 is hydrogen or methyl group, A is oxygen or NH, RR 8 is hydrogen or alkyl group, R 9 , R w and R 11 are alkyl groups, n is 0, 1 or 2, X is halogen)
(B) (3)で表される単量体  (B) the monomer represented by (3)
CH = C (R12) COOR13 (3) CH = C (R 12 ) COOR 13 (3)
2  2
(R12は水素又はメチル基、 R13はアルキル基) (R 12 is hydrogen or methyl group, R 13 is alkyl group)
(C)ノニオン性水溶性単量体  (C) Nonionic water-soluble monomer
を共重合してなるタンパク質付着防止用高分子化合物。 And a polymer compound for preventing protein adhesion.
【効果】 ガラス、セラミック、ステンレス、プラスチック等の硬表面、毛髪、繊維等の軟表面、ゲル 表面及びコンタクトレンズ表面に対して、低濃度かつ短時間処理によっても、耐久性があり優れ たタンパク質付着防止能を有するタンパク質付着防止用高分子化合物、並びにこれを含有し てなる組成物を提供することができる。 【選択図】 なし [Effect] Durable and excellent protein adhesion to hard surfaces such as glass, ceramics, stainless steel, plastics, etc., soft surfaces such as hair and fibers, gel surfaces and contact lens surfaces even at low concentration and for a short time. A polymer compound for preventing protein adhesion having an inhibitory ability, and containing the same A composition comprising: [Selection diagram] None
PCT/JP2004/016652 2004-05-13 2004-11-10 Polymer for preventing protein adhesion and composition containing the same WO2005111102A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-143177 2004-05-13
JP2004143177A JP4730506B2 (en) 2003-05-13 2004-05-13 High molecular compound for preventing protein adhesion and composition containing the same

Publications (2)

Publication Number Publication Date
WO2005111102A1 true WO2005111102A1 (en) 2005-11-24
WO2005111102A9 WO2005111102A9 (en) 2006-01-12

Family

ID=35394130

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/016652 WO2005111102A1 (en) 2004-05-13 2004-11-10 Polymer for preventing protein adhesion and composition containing the same

Country Status (2)

Country Link
TW (1) TW200536867A (en)
WO (1) WO2005111102A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02180911A (en) * 1988-12-09 1990-07-13 Kao Corp Film-forming resin and hair preparation containing same
JPH0482820A (en) * 1990-07-25 1992-03-16 Kao Corp Hair cosmetic
JPH0482819A (en) * 1990-07-25 1992-03-16 Kao Corp Hair cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02180911A (en) * 1988-12-09 1990-07-13 Kao Corp Film-forming resin and hair preparation containing same
JPH0482820A (en) * 1990-07-25 1992-03-16 Kao Corp Hair cosmetic
JPH0482819A (en) * 1990-07-25 1992-03-16 Kao Corp Hair cosmetic

Also Published As

Publication number Publication date
TW200536867A (en) 2005-11-16
WO2005111102A9 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
US4440662A (en) Cleaning composition for contact lenses
JP6001200B2 (en) Lens solution, contact lens and manufacturing method thereof
JP5623745B2 (en) Biguanide compositions with low terminal amines
KR101284386B1 (en) Copolymer and detergent compositions containing the same
EP0249663A1 (en) Cleaning composition with polymeric beads
US20180244911A1 (en) Composition, contact lens coating agent, method for producing contact lens, and contact lens
JPH02151693A (en) Detergent composition
EP1476529B1 (en) Antifouling detergent for hard surfaces
JP2002256030A (en) Tertiary amino group-containing high polymer compound, detergent composition, antifoulant composition and detergent antifoulant composition
US7544649B2 (en) Antifouling detergent for hard surfaces
US20100086514A1 (en) Contact Lens Care Solutions with a Low Molecular Weight Oligomer
US20040122128A1 (en) Coating material composition for dental prosthesis
JP5133882B2 (en) Contact lens solution and contact lens hydrophilization method using the same
JP3879844B2 (en) Detergent antifouling composition and detersive antifouling article
JP4328962B2 (en) Composition containing water film forming agent for contact lens
JP4730506B2 (en) High molecular compound for preventing protein adhesion and composition containing the same
CA2407325C (en) Low ionic strength ophthalmic compositions
JP2000239696A (en) Treating solution for contact lens
JP5352945B2 (en) Contact lens composition
TW200413520A (en) Compositions and methods for inhibiting protein on surfaces
JP4536175B2 (en) Preservative composition
WO2005111102A1 (en) Polymer for preventing protein adhesion and composition containing the same
JP4162316B2 (en) Treatment solution for contact lenses
JP2005208628A (en) Precare agent for contact lens and precare method of contact lens
JP4519949B2 (en) Contact lens solution composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: CLAIMS PAGES 28-29 DELETED REVENDICATIONS PAGES 28-29 SUPPRIMEES

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

122 Ep: pct application non-entry in european phase